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ABSTRACT
The present invention includes a composition for implanta
tion in a patient, comprising Surface-functionalized nanodia

monds and at least one biodegradable biocompatible poly
mer. The present invention also includes a Surgical fixation
device for use in a patient.
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1.
FUNCTIONALIZED NANODAMOND
REINFORCED BOPOLYMERS
CROSS-REFERENCE TO RELATED
APPLICATIONS

The present application is a 35 U.S.C. S371 national phase
application from, and claiming priority to, International
Application No. PCT/US2010/051176, filed Oct. 1, 2010,
and published under PCT Article 21(2) in English, which
claims priority to U.S. Provisional Application No. 61/248,
202, filed Oct. 2, 2009, which applications are incorporated
by reference herein in their entireties.
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BACKGROUND OF THE INVENTION
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Medical problems that affect bones, including fractures,
degenerative diseases and inflammatory syndromes, impact
millions of people worldwide. Bone fractures, lower back
pain, osteoporosis, Scoliosis and other musculoskeletal prob
lems generally require orthopedic intervention with the use of
permanent or temporary medical Surgical fixation devices.
The properties of these fixation devices play a key role in
determining the Success and recovery time for the medical
procedures.
Surgical fixation devices, including plates, screws, pins,
rods, anchors and Staples, are used in orthopedic Surgery
procedures, such as: bone fracture fixation (Weiler et al.,
1988, Am. J. Sports Med. 26(1): 119-28); autograft ankle
stabilization (Jeys et al., 2004, Am. J. Sports Med. 32(7):
1651-59); reconstruction surgery of the anterior cruciate liga
ment (ACL) and the posterior cruciate ligament (PCL) (Na
kano et al., 2000, Clin. Biomech. 5(3):188-95); replacement
of the intervertebral discs (Ella et al., 2005, J. Mat. Sci-Mat.
Med. 16(7):655-62); and posterior spinal fixation (Evans et
al., 2002, J. Mat. Sci-Mat. Med. 13(12): 1143-45).
Metal Surgical fixation devices are often used to replace
damaged or missing bone tissue due to their high initial fixa
tion strength (Kurosaka et al., 1987, Am. J. Sports Med.
15(3):225-29; Lambert, 1983, Clin. Orthop. Rel. Res. 172:
85-89; Shelbourne & Nitz, 1990, Am. J. Sports Med. 18(3):
292-99). However, metallic implant devices are not degrad
able, leaving cavitations in the bone once the devices are

and consist of an inert diamond core terminated with Surface
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carbon nanotubes (Shenderova et al., 2002, Crit. Rev. Solid
State Mat. Sci. 27(3–4):227-356). NDs exhibit the excellent
mechanical, thermal and electrical properties of diamond at
nanoscale, and actually outperform carbon nanotubes
(CNTs) and other known materials. For example, the thermal

conductivity of nanodiamonds (~2000 Wim' K') is of the
same order as the highest reported for CNTs (6600 W.m.
K') (Berber et al., Phys. Rev. Lett. 84(20):4613-16). How

ever, in contrast to carbon nanotubes, ND is a good insulator.

An attractive characteristic of NDs is their relative lack of
40
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tions from infections.

However, biocompatible polymer-based fixation devices
still face challenges. The polymer or composite used in the
devices should have good biocompatibility with the sur
rounding tissue and have mechanical properties similar to the
bone tissue being replaced. Furthermore, the polymer or com
posite should be biodegradable so that it is gradually replaced
by newly grown tissue (Claes et al., 1986, Akt. Traumatol.
16:74-77; Rokkanen et al., 1985, Lancet 1 (8443): 1422-24).
Most current biocompatible polymers are not strong enough

chemical groups such as C—O, COOH, and OH (Lam et al.,
2008, ACS Nano 2(10):2095-2102), as shown in FIG. 1.
When originally synthesized, the diamond core is often sur
rounded by graphene shells and amorphous carbon (FIGS. 1a
and 1b; Osswald et al., 2006, J. Am. Chem. Soc. 128(35):
11635-42).
NDs are a member of the nanocarbon family, but differ
from other well-known nanomaterials, such as fullerenes and

30

removed.

In recent years, Surgical fixation devices prepared with
biocompatible polymers have been investigated as potential
replacements of metallic fixation devices. Biocompatible
polymers have the potential to revolutionize biomedical engi
neering as scaffolds for hard and soft tissues, such as bone and
blood vessels. Compared with conventional metal fixation
devices, biocompatible polymer-based fixation devices have
the advantages of causing no long-term implant palpability,
no long-term temperature sensitivity, no stress shielding and
no interference with post-operative diagnostic imaging.
These advantages may lead to better bone healing, reduced
patient trauma, reduced cost, elimination of need for a Sub
sequent Surgery for implant removal, and fewer complica

2
from a mechanical standpoint, especially when used as Sur
gical fixation devices and bone scaffolds. Furthermore, cur
rent biocompatible polymer-based Surgical fixation devices
do not actively promote bone healing and regrowth, leaving
voids in the tissue once the implanted device is fully
degraded. There is thus a need to identify a polymer or com
posite material that combines structural strength and bone
tissue regrowth stimulation.
Nanosized diamond powders (also known as nanodia
monds or NDs) are produced by detonation synthesis in large
volumes (Shenderova & McGuire, “Nanocrystalline Dia
mond.” in “Nanomaterials handbook.Y. Gogotsi, Ed., 2006,
CRC Taylor and Francis: Boca Raton, p. 203-37) and repre
sent a new class of relatively inexpensive carbon nanomate
rial with a broad range of potential applications, including
composite materials. NDS have been used as components of
sorbents, lubricating and polishing compositions and as addi
tives to electrolytic and electroless deposition baths.
NDs are composed of particles of about 5 nm in diameter

60

toxicity and their biocompatibility. NDs have recently been
reported to be the least toxic of all carbon nanomaterials
(Puzyr et al., 2007, Diamond Relat. Mater. 16:2124-28;
Huang et al., 2007, Nano. Lett. 7(11):3305-14; Mitura et al.,
2006, J. Achiev. Mat. Manuf. Eng. 16(1-2):9-16; Bakowicz
Mitura, 2007, Surf. Coat, Technol. 201(13):6131-35; Lam et
al., 2008, ACS Nano.2(10):2095-2102: Liu et al., 2007, Nano
technol. 18(5):55102: Schrand et al., 2007, J. Phys. Chem. B
111(1):2-7; Puzyr et al., 2007, Diamond Relat. Mater.
16:2124-28). In contrast, the toxicity of CNTs is still debat
able and raises concerns regarding their use in biological
applications (Cherukuri et al., 2004, J. Am. Chem. Soc. 126
(48): 15638-39; Cherukuri et al., 2006, Proc. Natl. Acad. Sci.
U.S.A. 103: 18882-86).
The small particle size and the low toxicity of NDs make
them desirable for biological applications. Still, many poten
tial applications of NDs, including in biomedical and com
posite materials, remain unexplored.
There remains a need in the art to identify novel materials
that are compatible with biological systems and may have
used in biomedical applications. Such as orthopedic Surgery.
The present invention fulfills these needs.
BRIEF SUMMARY OF THE INVENTION

65

In one aspect, the invention includes a nanocomposite
material comprising Surface-functionalized nanodiamonds
and at least one biodegradable biocompatible polymer.

US 9, 186,190 B2
3
In one embodiment, the at least one biodegradable biocom
patible polymer is selected from the group consisting of
polyglycolic acid, polylactic acid, poly-L-lactic acid, poly
D/L-lactic acid with polyglycolic acid, poly-L-lactic acid-co
glycolic acid, PDLLA with bioactive glass, PLGA with bio
active glass, poly-L-lactic acid with B-tricalcium phosphate,
poly-L-lactic acid with hydroxyapatite, polydioxanone, poly
ethylene glycol, poly(s-caprolactone), polycaprolactone with
alginate, polyhydroxybutyrate, polycarbonate, N-Vinyl pyr
rolidone copolymers, polyorthoester, chitosan, poly(2-hy
droxyethyl-methacrylate), hyaluronic acid and a hydrogel. In
another embodiment, the at least one biodegradable biocom
patible polymer is selected from the group consisting of
polyglycolic acid, polylactic acid, poly-L-lactic acid, poly
D/L-lactic acid with polyglycolic acid, poly-L-lactic acid-co
glycolic acid, poly-L-lactic acid with B-tricalcium phosphate,
and poly-L-lactic acid with hydroxyapatite.

10

15

In one embodiment, the Surface-functionalized nanodia

monds are prepared from chemically-active nanodiamonds.
In another embodiment, the chemically-active nanodiamonds
comprise chemical groups selected from the group consisting
of carboxylate, carbonyl, amino and hydroxyl. In yet another

the anterior end of the screw, and

(b) filling the hollow core of the screw with a composition
comprising at least one bioactive agent selected from the
group consisting of a bone healing drug, growth factor,

embodiment, the Surface-functionalized nanodiamonds are

prepared by peptide bond formation between an amine and a
carboxylate group of the chemically-active nanodiamonds. In
yet another embodiment, the amine is selected from the group
consisting of octylamine, decylamine, undecylamine, dode
cylamine, tridecylamine, tetradecylamine, pentadecylamine,
hexadecylamine, heptadecylamine, dodecadecylamine,
nonadecylamine and eicosylamine. In yet another embodi
ment, the amine is octadecylamine.
In one embodiment, the at least one biodegradable biocom
patible polymer forms hydrogen-bond interactions with the
Surface-functionalized nanodiamonds. In yet another
embodiment, the at least one biodegradable biocompatible
polymer forms a covalent bond with the surface-functional
ized nanodiamonds. In yet another embodiment, the covalent
bond is an amide bond formed between a carboxylate group
of the at least one biodegradable biocompatible polymer and
an amino group of the Surface-functionalized nanodiamonds.
In yet another embodiment, the at least one biodegradable
biocompatible polymer is selected from the group consisting
of polyglycolic acid, polylactic acid, poly-L-lactic acid, poly
D/L-lactic acid with polyglycolic acid, poly-L-lactic acid-co
glycolic acid, poly-L-lactic acid with B-tricalcium phosphate,
and poly-L-lactic acid with hydroxyapatite.
In one embodiment, the material comprises 0.1% to 50% of

bone cell, bone stem cell, antibiotic, and anti-inflamma

25
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the Surface-functionalized nanodiamonds. In another

embodiment, the material further comprises a composition
comprising at least one bioactive agent selected from the
group consisting of a bone healing drug, growth factor, bone
cell, bone stem cell, antibiotic, and anti-inflammatory drug.
In another aspect, the invention comprises a Surgical fixa
tion screw. The screw comprises an intercoruective porous
shell, wherein the shell comprises a nanocomposite material
comprising functionalized nanodiamonds and at least one
biodegradable biocompatible polymer. The screw further
comprises a hollow core within the shell, wherein the hollow
core is closed on the posterior end of the screw and open on
the anterior end of the screw.

In one embodiment, the hollow core is optionally filled
with a composition comprising at least one bioactive agent
selected from the group consisting of a bone healing drug,
growth factor, bone cell, bone stem cell, antibiotic, and anti
inflammatory drug. In another embodiment, the posterior end
is tapered with respect to the anterior end. In yet another
embodiment, the screw has full-length taper. In yet another

4
embodiment, the anterior end is without head. In yet another
embodiment, the posterior end is rounded and blunt. In yet
another embodiment, the shell has controllable varying
coarseness, whereby phase of the nanocomposite material
around the hollow core is coarser than phase of the nanocom
posite material on outside surface of the screw. In yet another
embodiment, the controllable varying coarseness is achieved
through injection molding.
In yet another aspect, the invention includes a method of
performing an orthopedic Surgery procedure in a patient. The
method of the invention comprises the steps of:
(a) inserting a Surgical fixation screw in at least one orifice
of a bone or tissue of the patient. The screw comprises:
(a.1) an interconnective porous shell, wherein the shell
comprises a nanocomposite material comprising functional
ized nanodiamonds and at least one biodegradable biocom
patible polymer, and
(a.2) a hollow core within the shell, wherein the hollow
core is closed on the posterior end of the screw and open on

tory drug.
In one embodiment, the at least one biodegradable biocom
patible polymer is selected from the group consisting of
polyglycolic acid, polylactic acid, poly-L-lactic acid, poly
D/L-lactic acid with polyglycolic acid, poly-L-lactic acid-co
glycolic acid, PDLLA with bioactive glass, PLGA with bio
active glass, poly-L-lactic acid with B-tricalcium phosphate,
poly-L-lactic acid with hydroxyapatite, polydioxanone, poly
ethylene glycol, poly(e-caprolactone), polycaprolactone with
alginate, polyhydroxybutyrate, polycarbonate, N-Vinyl pyr
rolidone copolymers, polyorthoester, chitosan, poly(2-hy
droxyethyl-methacrylate), hyaluronic acid and a hydrogel. In
another embodiment, the posterior end is tapered with respect
to the anterior end. In yet another embodiment, the screw has
full-length taper. In yet another embodiment, the anterior end
is without head. In yet another embodiment, the posterior end
is rounded and blunt. In yet another embodiment, the shell has
controllable varying coarseness, such that phase of the nano
composite material around the hollow core is coarser than
phase of the nanocomposite material on outside Surface of the
screw. In yet another embodiment, the controllable varying
coarseness is achieved through injection molding.
BRIEF DESCRIPTION OF THE DRAWINGS

50

55

60

65

For the purpose of illustrating the invention, there are
depicted in the drawings certain embodiments of the inven
tion. However, the invention is not limited to the precise
arrangements and instrumentalities of the embodiments
depicted in the drawings.
FIG. 1, comprising FIGS. 1a-1d, is a series of high reso
lution transmission electron microscope (HR-TEM) images
(FIGS. 1a & 1c) and PM3 optimized molecular models
(FIGS. 1b & 1d) illustrating the structure of as-produced
(FIGS. 1a & 1b) and oxidized (FIGS. 1c & 1d) ND particles.
FIG. 2, comprising FIGS. 2a-2d. is a schematic represen
tation of the incorporation of 5-nm ND particles into poly
mer-matrix composites. FIG. 2a depicts agglomerated par
ticles, which lead to property degradation. FIG. 2b depicts
inert filler, without chemical interactions with the polymer.
FIG. 2C depicts polymer that is covalently bonded to disor
dered carbon shells. FIG. 2d depicts polymer chains that are
covalently bonded to the diamond surface.

US 9, 186,190 B2
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FIG. 3, comprising FIGS. 3a-3b, is a schematic represen
tation of covalently bound polymer-matrix composites using
CNTs (FIG.3a) and NDs (FIG. 3b) as a filler.
FIG. 4 is a schematic representation of the structure and
selected physical properties of nanodiamond samples. The
following legends apply: (a) as determined using transmis
sion electron microscope (TEM); (b) as determined using soft
X-ray absorption near-edge structure (XANES); (c) as
reported by supplier NanoBlox, Inc. (Boca Raton, Fla.,
USA). The following codes apply: (1) carbon onion; (2) nano
diamond; (3) fullerenic shell; (4) amorphous carbon; (5)
graphite ribbon.
FIG. 5 is a schematic representation of a bioactive interfer

6
FIG. 19, comprising FIGS. 19a–19d, illustrates the charac
terization of the ND-ODA particles. FIG. 19a is a graph
illustrating the ND-ODA particle size in PLLA/chloroform
solution. Particle size measurement showed 32 nm and 28 nm.

ND-ODA agglomerates in 1% wt (curve 1) and 10% wt
(curve 2) ND-ODA/PLLA-chloroform solution, respectively.
The small particle size corresponded to ND-ODA aggregates
composed of less than 5 ND-ODA particles in an aggregate
cross-section. FIGS. 19b-d illustrate low resolution TEM
10

micrographs of ND-ODA/PLLA thin cross-sections, sug
gesting a uniform dispersion of small clusters of ND-ODA in
the PLLA matrix at concentrations 1% (FIG. 19b), 3% (FIG.
19C), and 10% (FIG. 19d). No micron-sized aggregates were
observed. With the increasing ND-ODA concentration, inter

15

connected chains were formed between ND-ODA clusters

CCSCW.

FIG. 6 is a schematic representation of a GCS (gradient
cellular structure) mold with a heated core. The core tempera
ture and the mold temperature may be controlled separately to
create the desired thermal gradient.
FIG. 7 is a graph depicting the FT-IR spectra of ND (linea),
NDacyl chloride (lineb), ODA (octadecylamine; line c), and
ND-ODA (lined).
FIG. 8 is a graph depicting the UV Raman spectrum of
ND-ODA powder.
FIG. 9 is a graph demonstrating the particle size of ND
ODA in toluene (line 1) and chloroform (line 2). The inset is
a photograph of 0.01% wt suspensions of ND and ND-ODA

(FIG. 19d).
FIG. 20, comprising FIGS. 20a-fillustrates representative
load-displacement curves (FIG.20a) and stress-strain curves
(FIG. 20b) of pure PLLA and ND-ODA/PLLA composites
with 1% wt and 10% wt of ND-ODA. FIGS. 20a and 20b
illustrate that the increase in ND-ODA content results in a

25

in toluene.

FIG. 10, comprising FIGS. 10a-10d, is a series of images
comparing the nanodiamond dispersion in PLLA. The dis
persion of ND-ODA in PLLA/chloroform solution was stable
(day 1, FIG. 10a; and day 9, FIG. 10b). In contrast, most of
NDs precipitated from PLLA/chloroform solution after one
day (day 1, FIG. 10c; and day 2, FIG. 10d).
FIG. 11 is a bar graph comparing the hardness of PLLA
ND with different content of NDs and ND-ODA (% wt).
FIG. 12, comprising FIGS. 12a-12b, is a series of graphs
depicting the hardness and Young's modulus of PA-1 1/ND
films with different contents of nanodiamond (FIG. 12a).
Indentation curves for epoxy/ND composites with different
contents of nanodiamond are depicted in FIG.12b.
FIG. 13, comprising FIGS. 13a-13b, is a series of images
depicting the bisbenzimide nuclear staining of adherent
U2OS cells following 72 hours of seeding on pure PLLA
(FIG. 13a, 100x) and ND-ODA/PLLA composite (0.5% wt
ODA) (FIG. 13b, 100x) scaffolds. Images were captured by
imaging the Surface of a strut on the outside of the scaffolds.
FIG. 14 is a graph that demonstrates the heat flow during
DSC measurement of pure PLLA, 3% wt ND-ODA/PLLA
and 5% wt ND-ODA/PLLA composites.
FIG. 15, comprising FIGS. 15a-15b, is a series of images of
different porous structures obtained through different pro
cessing conditions: FIG. 15a, without dwell time inside the
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film. Bottom curve in FIG.20e illustrates the XRD of 10% wt

of an ND-ODA/PLLA film. Both patterns showed Bragg
peaks of PLLA, which are, in case of the pure PLLA film,
seen atop of a strong amorphous halo indicating less crystal
linity of PLLA as compared to the 10% wt ND-ODA/PLLA,
Narrower and more intense peaks of 10% witND-ODA/PLLA
also confirmed the higher crystallinity of the composite. FIG.
20f is a table Summarizing the mechanical properties deter
mined by depth sensing indentation.
FIG. 21, comprising FIGS. 21a-d, illustrates SEM images
of a 10% wt ND-ODA/PLLA thin film produced through
solution casting. FIG. 21a illustrates the porous structure of
the film, which facilitates cell attachment and growth. Due to
the presence of ND-ODA in the PLLA matrix around pores,
the film shows blue and red fluorescence (shown as light areas
in the figures reproduced herein) under excitation with 360
nm (FIG. 21b) and 555 nm (FIG. 21c). Fluorescence patterns
coincided with the porous structure observed under SEM.
The clear fluorescence of the 10% wt ND-ODA/PLLA Scaf
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fold (FIG. 21d) seen in the background of 7F2 osteoblasts
after 3 days post-seeding indicated the possibility to monitor
the composite degradation in situ through the fluorescence
observation.

intruder; and FIG. 15b, with dwell time inside the intruder.

FIG. 16 is an image of a skin-core structure in injection
molded blends.

pronounced reduction of creep and leads to an increase in
hardness and Young's modulus of the nanocomposites. Com
parison of Vickers indents on pure PLLA (FIG. 20c) and 10%
ND-ODA/PLLA composite (FIG. 20d) provided a further
evidence of a dramatic improvement in the elastic recovery of
the ND-ODA/PLLA samples. FIG.20e illustrates XRD pat
terns of pure PLLA and 10% wt ND-ODA/PLLA thin films.
Upper curve in FIG.20e illustrates the XRD of a pure PLLA
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FIG. 17 is a bar graph demonstrating the molecular weight
change of composites as a function of incubation time.
FIG. 18, comprising FIG.18a-18d, illustrates the compos
ites of the invention. FIG.18a is a schematic illustration of the

manufacturing and use of ND-ODA/PLLA composites. FIG.
18b is an illustrative molecular model of an ND-ODA par
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sentation of a high resolution TEM illustrating an ND-ODA
cluster where pristine nanodiamond particles are surrounded
by ODA chains.
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ticle. FIG. 18c is an illustrative comparison between 'C
MASNMR spectra for UD90-ODA obtained via direct polar
ization and H to C cross polarization. FIG. 18d is a repre

FIG. 22, comprising FIGS. 22a-fillustrates the morphol
ogy of 7F2 osteoblasts on pure PLLA and 10% wt ND-ODA/
PLLA. The morphology of these cells at 2 and 6 days of
post-seeding on pure PLLA (FIGS. 22a and 22c) and 10% wt
ND-ODA/PLLA (FIGS. 22b and 22d) are illustrated. Cell
morphology of 2 days post-seeding on PLLA (FIG. 22a) and
10% wt ND-ODA/PLLA (FIG.22b) suggests that the attach
ment of osteoblasts on the surface of 10% wt ND-ODA/

PLLA scaffold was as good as on the surface of a pure PLLA
scaffold. Staining for nuclei was bis-benzimide (blue) and for
actin cytoskeleton-phalloidin (red). SEM images of 7F2
grown on the different scaffolds after 6 days post-seeding:
osteoblasts spread to confluence similarly on the Surface of
pure PLLA (FIG. 22e) and 10% wt ND-ODA/PLLA (FIG.
22?) scaffolds.

US 9, 186,190 B2
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FIG. 23 is a bar graph illustrating real-time quantitative
PCR analysis of gene expression for osteogenic marker genes
alkaline phosphatase (ALP) and osteocalcin (OCN) in 7F2
osteoblasts cultured for 48 h and 1 week on pure PLLA, 10%
wt ND-ODA/PLLA and 10% wt UD90/PLLA post-seeding
(*ANOVA: p-0.05). Data are expressed in meantstandard
error (n=3).
FIG. 24 is a bar graph illustrating a cytotoxicity test for ND
and ND-ODA. Cell viability assay (alamarBlueTM (AB)
based) of 7F2 mouse osteoblasts grown on tissue culture
plastic (TCP) in the presence of ND or ND-ODA. Error bars
represent the standard deviation for each sample (n-6).
FIG. 25 is a bar graph illustrating biocompatibility test for
ND-ODA/PLLA composites, Normalized increase in AB
readings was monitored for 6 days in vitro 7F2 cell culture on
pure PLLA, ND-ODA/PLLA (1-10% wt of ND-ODA), and
control glass and TCP substrates. Metabolic activities were
measured by AB assay every three days following the 24h
seeding period. The data were normalized to the AB fluores
cence reading at day 0. Error bars represent the standard
deviation from the mean for each sample (n=6).

8
invention belongs. Generally, the nomenclature used herein
and the laboratory procedures in cell culture, molecular
genetics, organic chemistry, and peptide chemistry are those
well known and commonly employed in the art.
As used herein, the articles “a” and “an refer to one or to

more than one (i.e. to at least one) of the grammatical object
of the article. By way of example, “an element’ means one
element or more than one element.
10

on the context in which it is used.
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DETAILED DESCRIPTION OF THE INVENTION

The present invention relates to the discovery that a novel
biomedical nanocomposite material comprising a biodegrad
able biocompatible polymer and surface-functionalized
nanodiamonds may be utilized for the development of scaf
folds and surgical fixation devices for bone repair. These
novel materials are strong from a mechanical standpoint and
Suitable for use in Surgical fixation devices and bone scaf
folds. These novel materials are biocompatible and biode
gradable, and preferably stimulate the regeneration of the
original biological material that is being replaced, avoiding
cumbersome and potentially problematic follow-up proce
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In one aspect, the invention provides a composition com
prising a biodegradable biocompatible polymer and Surface
functionalized nanodiamonds for implantation in a patient.
monds interact with the polymer, ensuring that the nanodia
mond particles are well dispersed within the polymer-nano
diamond composite. Optionally, the composition further
comprises at least one bioactive agent selected from the group
consisting of a bone healing drug, growth factor, bone cell,
bone stem cell, antibiotic, and anti-inflammatory drug. These
bioactive agents may accelerate bone healing, bone growth,
tissue growth and/or Surgical recovery.
In another aspect, the invention provides a Surgical fixation
device for use in a patient, wherein the device comprises a
composition comprising a biodegradable biocompatible
polymer and Surface-functionalized nanodiamonds. The
device is comprised of materials that have a proven safety
record and have sufficient mechanical strength. Optionally,
the devise further comprises at least one bioactive agent
selected from the group consisting of a bone healing drug,
growth factor, bone cell, bone stem cell, antibiotic, and anti
inflammatory drug. The device may further promote faster
bone growth than existing devices.
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As used herein, each of the following terms has the mean
ing associated with it in this section.
Unless defined otherwise, all technical and scientific terms

particle'. “ND” and “nanosized diamond powder are used
interchangeably and refer a carbon nanomaterial composed
of particles with about 5 nm in diameter consisting of an inert
diamond core and Surface chemical groups.
As used herein, the term “patient” refers to a human or a
non-human animal. Non-human animals include, for

40

DEFINITIONS

used herein generally have the same meaning as commonly
understood by one of ordinary skill in the art to which this

As used herein, the term “biocompatible polymer refers to
a polymeric material that does not cause inflammatory or
immune response in the body. As used herein, the term “bio
degradable polymer refers to a polymeric material that
undergoes degradation when placed inside the body and gen
erates non-toxic degradation products, which may be elimi
nated by the body as such or metabolized into one or more
non-toxic molecules. Non-limiting examples of biodegrad
able biocompatible polymers are: polyglycolide or polygly
colic acid (PGA); polylactide or polylactic acid (PLA); poly
L-lactic acid (PLLA); poly-D/L-lactic acid with polyglycolic
acid (PDLLA-co-PGA); poly-L-lactic acid-co-glycolic acid
(PLGA); PDLLA with bioactive glass; PLGA with bioactive
glass; poly-L-lactic acid with 3-tricalcium phosphate (PLLA
TCP); poly-L-lactic acid with hydroxyapatite (PLLA-HA);
polydioxanone (PDS); polyethylene glycol (PEG); poly(ecaprolactone) (PCL); polycaprolactone (PCL) with alginate:
polyhydroxybutyrate (PHB); polycarbonate (PC); N-vinyl
pyrrolidone copolymers; polyorthoester, chitosan, poly(2hydroxyethyl-methacrylate) (PHEMA): hyaluronic acid and
hydrogels.
As used herein, the terms "nanodiamond”. “nanodiamond

dures.

The chemical moieties located on the surface of the nanodia

As used herein, the term “about will be understood by
persons of ordinary skill in the art and will vary to some extent
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example, livestock and pets, such as ovine, bovine, porcine,
canine, feline and murine mammals, as well as reptiles, birds
and fish. Preferably, the patient is human.
Biodegradable Polymers for Use in Surgical Fixation Devices
Increased interest in biodegradable Surgical tools for bone,
ligament, tendon and graft fixations has led to the develop
ment of Surgical fixation devices made of biopolymeric mate
rial. Biodegradable polymers of synthetic and natural origin,
Such as, but not limited to, polyglycolide or polyglycolic acid
(PGA), polylactide or polylactic acid (PLA), poly-L-lactic
acid (PLLA), poly-D/L-lactic acid with polyglycolic acid
(PDLLA-co-PGA), poly-L-lactic acid-co-glycolic acid
(PLGA), PDLLA with bioactive glass, PLGA with bioactive
glass, poly-L-lactic acid with 3-tricalcium phosphate (PLLA
TCP), poly-L-lactic acid with hydroxyapatite (PLLA-HA),
polydioxanone (PDS), poly(e-caprolactone) (PCL), polyca
prolactone (PCL) with alginate, polyhydroxybutyrate (PHB),
polycarbonate (PC), N-vinyl pyrrolidone copolymers, poly
orthoester, chitosan, poly(2-hydroxyethyl-methacrylate)
(PHEMA). PEG (polyethylene glycol), hyaluronic acid and
other hydrogels, were extensively studied.
The concept of bioabsorbable (or biodegradable) material
was introduced by Kulkarni and coworkers in the 1960s
(Kulkarni et al., 1966, Arch. Surg. 93:839; Kulkarni et al.,
1971, J. Biomed. Mater. Res. 5: 169-181). In the last decades,
these materials have been used in many orthopaedic applica
tions such as bone Substitution, repair of bone fractures (in
cluding ligament fixation), cartilage, meniscus and interver
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tebral disc. They are used as Sutures, rods, screws, pins and
plates (Ciccone et al., 2001, J. Am. Acad, Orthop. Surg.
9:280-288).
The bioabsorbable polymers included in the invention may
be processed following similar procedures as those used for
thermoplastics. They may be melted and extruded, molded by
injection or compression or solvent cast, but the presence of
moisture must be carefully controlled, because their hydro
lytic sensitivity leads to a significant decrease in the materi
als molecular weight. Therefore, the polymer included in the
invention has to be kept completely dry before thermally
processing, and its contact with moisture during the process
ing must be avoided.
Biodegradation of the biopolymers included in the inven
tion is mainly caused by hydrolysis of the polymer chain
backbone and to a lesser extent by enzymatic activity (Vert &

Nanodiamonds as Fillers

Nanodiamonds (NDs) are comprised of particles that are
about 5 nm in diameter. In one embodiment, the NDs used in
5

10

from 4 nm to 6 mm.
The use of NDs as fillers within the invention is advanta
15

Li, 1992, J. Mater. Sci. Mater. Med. 3:432-446; Li & McCar

thy, 1999, Biomaterials 20:35-44). Degradation times depend
on multiple factors, such as polymer crystallinity, molecular
weight, thermal history, porosity, monomer concentration,
geometry and the location of the implant.
The biopolymers included in the invention comprise PLA,
PDS, PGA, and PLGA, which are amongst the most com
monly used synthetic, biodegradable polymers, with an
extensive U.S. FDA approval history (Ella et al., 2005, J. Mat.
Sci.-Mat. Med. 16(7):655-662; Huh et al., 2005, Drug Del.
Tech. 3(5):52-58).
PGA is a highly crystalline hydrophilic polymer, which
tends to lose its mechanical strength rapidly (50% loss over a
period of 2 weeks). Upon implantation, PGA degrades in
about 4 weeks and can be completely absorbed in 4-6 months
(Grayson et al., 2005, Biomaterials 26(14):2137-2145; Ouy
anget al., 2002, Mat. Sci. & Eng. C: Biomim. Supramol. Syst,
20(1-2): 63-69; Zhang et al., 2006, Pol. Degr. Stab. 91(9):
1929-1936; Panyam et al., 2003, J. Contr, Rel. 92(1-2):173
187; Oh et al., 2006, J. Mat. Sci-Mat. Medicine 17(2):131
137; Valimaa & Laaksovirta, 2004, Biomaterials 25(7-8):
1225-1232; Habraken et al., 2006, J. Biomat. Sci.-Pol. Ed.

17(9): 1057-1074).
PGA is more hydrophilic and PLA has a high modulus that
makes it more Suitable for load-bearing applications. For
PLGA copolymers, the mechanical strength and the degrada
tion rate depend on the ratio of PLA/PGA. As the content of
PLA in the PLGA copolymer increases, the copolymer
becomes mechanically stronger and degrades more slowly. In
the case of PLA, PLGA and PGA, the final products of the
polymer degradation are the acidic monomers (lactic acid and
glycolic acid, respectively) that are metabolized to ATP, water
and CO (Brady et al., 1973, J. Biomed. Mater. Res. 7:155
166). PLGA degradation is also influenced by other factors
including the polymer chain length and characteristics of the
Surrounding medium.
Chitosan, PHEMA, PEG and hyaluronic acid are biopoly
mers also included in the invention. They are among the most
relevant hydrogels used in the generation of biomaterials. In
hydrogels the bonding of hydrophilic macromolecules by
means of covalent hydrogen and ionic bonds form a three
dimensional network that is able to retain large amounts of
water in their structure. These types of polymers are useful in
cartilage, ligaments, tendons and intervertebral disc repair
applications (Ambrosio et al., 1996, J. Mater. Sci, Mater.
Med. 7:525-530). Chitosan is a weak cationic polysaccharide
obtained by extensive deacetylation of chitin and composed
essentially of B(1->4) linked glucosamine units together with
Some N-acetylglucosamine units.

the invention vary in diameter from 0.1 nm to 50 nm. In
another embodiment, the NDs used in the invention vary in
diameter from 0.5 nm to 25 nm. In yet another embodiment,
the NDs used in the invention vary in diameter from 1 nm to
10 nm. In yet another embodiment, the NDs used in the
invention vary in diameter from 2 nm to 8 nm. In another
embodiment, the NDs used in the invention vary in diameter
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geous because of the high matrix/filler interface area when the
size of the filler particles approaches nanometer domain. By
dispersing a mere 1% Vol of a nanoparticle of radius ~2 nm in
a polymer (interfacial thickness ~6 nm), the Volume fraction
occupied by the interface region is ~63%, Suggesting that
more than half of the composite is affected by the presence of
the second-phase particles (Winey & Vaia, 2007, MRS Bul
letin 32:314-319). Thus, being well dispersed, the NDs
included in the invention improve properties of the compos
ites at very low concentrations without compromising the
properties of the matrix. Furthermore, the ability of nanopar
ticles, such as the NDs of the present invention, to penetrate
through blood-brain barrier is unique and may be utilized in
drug delivery systems (Kreuter, 2004, J. Nanosci. Nanotech
nol. 4(5):484-488; Muller & Keck, 2004, J. Nanosci. Nano
technol. 4(5):471-483).
Surface-Functionalized Nanodiamonds and Chemically-Ac
tive Nanodiamonds

Non-functionalized ND particles tend to form unusually
tight aggregates (Krueger, 2008, J. Mater. Chem., 18:1485
1492). Mixing non-functionalized ND particles with a poly
mer typically results in poor dispersion with micron-sized
nanodiamond agglomerates embedded in the matrix (FIG.
2a). Aggregated ND particles do not produce any property
improvement for the composite, acting rather as defects and
often leading to deterioration in mechanical properties.
By contrast, functionalized NDS tend not to aggregate
within the composite, but rather produce a uniform distribu
tion of NDs in the composite (FIG. 2b). Even when well
dispersed, however, the NDs act merely as conventional
nanofillers with high hardness, performing similar to other
ceramic nanoparticles (such as silica or clay) and leading to
only moderate improvements in properties. In other words,
good dispersion of the nanoparticles in the composite is not
sufficient to ensure that the composite will have superior
mechanical and thermal properties. A strong interface
between the surface derivatized NDs and the matrix must also
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be present to ensure Superior mechanical properties for the
corresponding composite, and methods must be developed
for the rationale modification of the surface of the ND par
ticle.
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In one embodiment, the strong interface between the Sur
face derivatized NDs and the matrix is obtained by hydrogen
bonds between the matrix and the surface derivatized NDs. In

another embodiment, the strong interface between the surface
derivatized NDs and the matrix is obtained by covalent bonds
between the matrix and the surface derivatized NDs. These
60
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bonds are favored because surface derivatized NDs present a
large number of functional groups on their Surface and are
thus able to engage in multiple interactions (FIG. 3b). On the
other hand, CNTs have only a small number of functional
groups, located at the end of the tubes, and are thus limited in
their ability to interact with the matrix (FIG.3a).
Nanodiamonds included in the invention may be obtained
from commercial sources, such as NanoBlox, Inc. (Boca
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Raton, Fla., USA). This manufacturer provides nanodia
monds in different grades: UD50, UD90 and UD98 grades,
wherein the number in the grade roughly corresponds to the
diamond-to-graphite ratio in the material. The properties of
Such materials are Summarized in FIG. 4.

Nanodiamonds included in the invention may present
chemical groups on their Surface. Such nanodiamonds are
generally referred to as “chemically-active nanodiamonds.”
Chemically-active nanodiamonds may be manipulated by
standard chemical methods to yield derivatized nanodia

12
tion (I). H annealing may not significantly remove non
diamond carbon from the sample.
O

R

15

Generation of chemically-active NDs included in the
invention may be done in numerous ways, including tradi
tional gas and wet chemistry (Osswald et al., 2006, J. Am.
Chem. Soc. 128(35): 11635-11642; Mochalin et al., 2007,
“High Temperature Functionalization and Surface Modifica

O-R

Vco = 1770 cm
25
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at 800° C. This treatment increases the content of C H

R

O

Cl2

(II)

ND

-e-

C

Vco = 1810 cm

where R is H or a carbon-based group, such as CH. Chlori
nation may also remove carbon from the material due to the
formation of volatile CC1.
In yet another embodiment of the invention, the chemi
cally-reactive NDs are prepared by ammonia treatment of
NDs for 1 hour at 850° C. This treatment may give rise to
NH-containing groups on nanodiamonds. This treatment
may also give rise to C. H. C=N and O H containing
Surface functionalities.
Functionalization of the Surface of ND Particles
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In one embodiment, the surface of the chemically-active
nanodiamond particles included in the invention comprises
carboxylic groups (—COOH). Chemically-active NDs with
COOH Surface groups have good dispersion stability in aque
ous solutions at basic pH (Osswald et al., 2006, J. Am. Chem.
Soc. 128(35): 11635-11642). Carboxylic groups on the sur
face of chemically-active nanodiamonds may be derivatized
using methods known to those skilled in the arts.
As a non-limiting example, the carboxylic groups on the
Surface of chemically-active nanodiamonds may be reacted
with an activating agent, Such as, but not limited to, EDC
(1-ethyl-3-(3-dimethylaminopropyl)carbodiimide), DCC
(dicyclohexylcarbodiimide) or DIC (N,N'-diisopropylcarbo
diimide), in an inert Solvent such as, but not limited to, dichlo
romethane, tetrahydrofuran or dimethylformamide, and then
reacted with a primary or secondary amine, yielding Surface
functionalized NDs with immobilized amides.

55

as C—O, COOH, and OH, with a decrease in the content of

containing groups and completely removes C=O groups as a
result of saturation of non-saturated bonds according to reac

H

In yet another embodiment of the invention, the chemi
cally-reactive NDs are prepared by chlorine (Cl) treatment
of NDs for 1 hour at 400° C. This treatment yields acyl
chlorides, as shown in reaction (II):

ND

graphitic sp°-bonded carbon.

C-H groups. Carboxyl groups can be easily deprotonated in
basic media, thus aqueous Suspensions of the oxidized ND
have lower aggregation tendencies at pH>7.
In another embodiment of the invention, the chemically
reactive NDs are prepared by high temperature treatment of
NDs in H atmosphere. In yet another embodiment, the high
temperature treatment of NDs in H atmosphere is for 2 hours

ND

O

tion of Nanodiamond Powders. In "Materials Research Soci

Oxidative purification may be conducted under isothermal
conditions using a THM600 Linkam heating stage (Linkam
Scientific Instruments Ltd., Tadworth, Surrey, UK) and a tube
furnace, and under non-isothermal conditions using a ther
mobalance (Perkin-Elmer TGA 7. Shelton, Conn., USA).
Isothermal experiments include two steps: (i) rapid heating at
50° C./min to the selected temperature and (ii) isothermal
oxidation for 5 hours in ambient air at atmospheric pressure.
In one embodiment, the temperature range for oxidation of
the ND samples investigated is 400-430° C.
Under these conditions, the purity of ND may become
comparable to that of microcrystalline diamond. Metal impu
rities, which are initially protected by carbon shells in the
commercial samples, generally become accessible after oxi
dation and are completely removed by further treatment in
diluted acids. In addition to purification, air oxidation dra
matically changes the surface chemistry of ND (FIG. 1).
Oxidation of the nanodiamond particles results in nanopar
ticles covered by oxygen-containing functional groups such

-e-

10

are prepared by chemical modification of chemically-active
nanodiamonds. In another embodiment, chemically-active

ety Symposium Proceedings. Boston, Mass., USA, Vol.
1039, No. 1039-P11-03). These methods allow for the gen
eration of chemically-active nanodiamonds with different
Surface functional groups, which may be used as handles to
introduce chemical groups on the surface of the NDs (“sur
face derivatization').
Among the methods for generating chemically-active NDS
that are contemplated by the invention are air oxidation,
hydrogenation, chlorination and ammonia treatment (Mocha
lin et al., 2009, Mater. Res. Soc. Symp. Proc. 1039, 1039
P11-03).
In one embodiment of the invention, the chemically-reac
tive NDs are prepared by air oxidation of NDs. Air oxidation
(or oxidative purification) affords NDs free of amorphousand

OH

H

ND

monds, such as Surface-functionalized nanodiamonds.
In one embodiment, Surface-functionalized nanodiamonds

nanodiamonds are themselves Surface-functionalized nano
diamonds and are used as Such within the invention.

(I)

5
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In one embodiment, the amine is selected from the group
consisting of octylamine, decylamine, undecylamine, dode
cylamine, tridecylamine, tetradecylamine, pentadecylamine,
hexadecylamine, heptadecylamine, dodecadecylamine,
nonadecylamine and eicosylamine. In another embodiment,
the amine is octadecylamine.
In another non-limiting example, the carboxylic groups on
the surface of chemically-active NDs may be reacted with a
chlorinating agent. Such as, but not limited to, thionyl chlo
ride, phosgene, diphosgene or triphosgene, in an inert Solvent
such as, but not limited to, dichloromethane, tetrahydrofuran
or dimethylformamide, and then reacted with a primary or
secondary amine, yielding Surface-functionalized NDS with
imnobilized amides.

In another embodiment, the surface of the chemically
active nanodiamond particles included in the invention com
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prises amino groups (-NH2). Amino groups may be intro
duced on the Surface of the chemically-active nanodiamonds
by treating nanodiamonds with ammonia at high temperature.
Amino groups may also be introduced on the Surface of the
chemically-active nanodiamonds by attaching bisamines to
nanodiamonds containing Surface carboxylic groups.
As a non-limiting example, the carboxylic groups on the
Surface of chemically-active nanodiamonds may be reacted
with (i) an activating agent, Such as, but not limited to, EDC
(1-ethyl-3-(3-dimethylaminopropyl)carbodiimide), DCC
(dicyclohexylcarbodiimide), or DIC (N,N'-diisopropylcarbo
diimide), in an inert Solvent such as, but not limited to, dichlo
romethane, tetrahydrofuran or dimethylformamide, or (ii)
with a chlorinating agent, such as, but not limited to, thionyl
chloride, phosgene, diphosgene or triphosgene, in an inert

14
functionalized NDs. In yet another embodiment, the nano
composite material comprises 6% to 12% of surface-func
tionalized NDs. In yet another embodiment, the
nanocomposite material comprises 8% to 12% of surface
functionalized NDs.

10

bonds between the surface-functionalized NDs and the

15

solvent such as, but not limited to, dichloromethane or tet

rahydrofuran. The material may then be reacted with a
bisamine, in an inert solvent such as, but not limited to,

dichloromethane, tetrahydrofuran or dimethylformamide. In
one aspect, the bisamine may have both amine groups in
unprotected form, in which case the reaction yields an immo
bilized amide with a free amino group. In another aspect, the
bisamine may have one unprotected amino group and one
protected amino group, wherein the protective group may be,
for example, t-butoxycarbonyl (Boc) or fluorenylmethoxy
carbonyl (Fmoc). In this case the reaction yields an immobi
lized amide with a protected amino group. The protective
group may be removed using conditions well known in the
art, such as treatment with trifluoroacetic acidorhydrochloric
acid in the case of the Boc protective group, or treatment with
piperidine in dimethylformamide in the case of the Fmoc
protective group. This procedure yields surface-functional
ized NDS with amides containing free amines.
Formation of Bonds Between Surface-Functionalized ND
Particles and Matrix

An important aspect of be considered in the preparation of
nanodiamond-polymer composites included in the invention
is the purity level of the starting ND particles. The content of
non-diamond phase in as-produced or commercially avail
able NDs may be as high as 75% wt. Purification of as
received or crude NDS using modification methods such as,
but not limited to, air oxidation, hydrogenation, chlorination
and ammonia treatment, and optional mechanical methods

A strong interface between the surface-functionalized NDs
included in the invention and the matrix must be present to
ensure improved mechanical properties for the composite
contemplated in the invention. One Such strong interface may
be obtained by forming strong covalent or non-covalent
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matrix. In this case, for each polymer matrix, the Surface
functionalized NDs would contain surface groups capable of
forming strong hydrogen bonds or covalent bonds with the
molecules of polymer matrix (FIG. 2d). Covalent bond for
mation between the purified surface-functionalized ND par
ticles and polymer matrix will eventually lead to a “super
composite', a material that should fully realize the superior
mechanical and thermal properties of ND nanodiamond.
In a non-limiting example, PLLA matrix and NH2-termi
nated ND may be used to generate a covalently bound ND
matrix composite. PLLA matrix contains free terminal
—COOH groups, which may be reacted with NH-termi
nated ND in the presence of a coupling reagent, such as, but
not limited to, DCC (dicyclohexylearbodiimide), EDC
(1-ethyl-3-(3-dimethylaminopropyl)carbodiimide), or DIC
(N,N'-diisopropyl-carbodiimide), in an inert solvent such as,
but not limited to, dichloromethane, tetrahydrofuran or dim
ethylformamide. This reaction results in amide bonds
between the surface-functionalized ND particle and PLLA
chains, as shown in reaction (III),

35
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Such as, but not limited to, treatment with acidic Solutions,

results in non-diamond carbon removal and generation of a
material with the surface uniformly terminated by specific
functional groups. In a non-limiting example, selective air
oxidation of as-received ND in controlled conditions may
increase the content of diamond phase from ~25 up to ~95%
wit, and convert diverse surface functional groups of non
purified ND into C=O and COOH (Osswald et al., 2006, J.
Am. Chem. Soc. 128(35): 11635-11642).
In one embodiment, the nanocomposite material com
prises 0.1% to 50% of surface-functionalized NDs. In another
embodiment, the nanocomposite material comprises 0.5% to
50% of surface-functionalized NDs. In yet another embodi
ment, the nanocomposite material comprises 0.75% to 40%
of surface-functionalized NDs. In yet another embodiment,
the nanocomposite material comprises 1% to 30% of surface
functionalized NDs. In yet another embodiment, the nano
composite material comprises 2% to 25% of surface-func
tionalized NDs. In yet another embodiment, the
nanocomposite material comprises 3% to 20% of surface
functionalized NDs. In yet another embodiment, the nano
composite material comprises 4% to 20% of surface-func
tionalized NDs. In yet another embodiment, the
nanocomposite material comprises 5% to 15% of surface

(III)
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In another non-limiting example, PLLA matrix and—NH
or —COOH groups on the surface of functionalized ND
powders may be used to form strong hydrogen bonds between
the PLLA matrix and the ND particles.
In yet another non-limiting example, PLLA matrix and
HO-terminated ND may be used to generate a covalently
bound ND-matrix composite. PLLA matrix contains free ter
minal —COOH groups, which may be esterified with OH
terminated ND in the presence of a coupling agent such as
DCC. Alternatively, the PLLA matrix may be treated with a
chlorinating agent, such as thionyl chloride, to effect conver
sion of the carboxylic acid groups into acyl chloride groups.
This material may then be reacted with HO-terminated ND to
yield ester-linked ND-PLLA composites. Such chemical
approaches may be extended to other polymers contemplated
in the invention, depending on the specific functional groups
that they contain.
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Surgical Fixation Devices Containing Derivatized ND Par
ticles

Surgical fixation devices are crucial for the treatment of
bone-related problems. For example, more than 90,000 ante
rior cruciate ligament (ACL) reconstructive Surgeries are per
formed annually worldwide (Bangash, "Trauma An Engi
neering Analysis. Springer Berlin Heidelberg, 2007). This
procedure involves replacing the torn ligament with new tis
Sue (a graft), repairing and/or replacing the damaged ACL and
dealing with knee instability, pain and recurrent Swelling. For
this, Small holes are drilled in the bone, and the graft is passed
through these holes. These grafts are then held in place and
fixed using a wide range of Surgical devices, such as plates,
Staples, anchors, interference screws and transverse pins.
Good initial fixation of the properly positioned and tensioned
graft is critical.
ACL procedures and other in bone/tissue structure fixation
procedures would benefit from the development of a novel
Surgical fixation device that combines the property of Sup
porting weight and providing Support with the ability to even
tually allow for regrowth of the bone material. The devices
contemplated in the present invention address these uses.
The bioactive surgical fixation devices of the present inven
tion are multi-functional. On one hand, they have the neces
sary stiffness and strength to be used in Surgical procedures.
On the other hand, they comprise a permeable medium that is
able to deliver bioactive agents to the environment.
Nature is an excellent producer of similar multifunctional
structures, e.g., wood, eggshell, wheat and rice, bone, skin,
and others. These naturally porous materials all have a gra
dient cellular structure (GCS), with the porosity distributed in
space so as to maximize the overall performance of the struc
ture (Zhang et al., 2005, J. Zhejiang Univ. Sci. 6a(10):1095
1099: Kumar, 1993, Cell. Pol. 12(3):207-223; Suh, 2003,
Macromol. Symp. 201:187-201: Gong et al., 2005, Int. Pol.
Proc. 2002):202-214; Kitimasak et al., 2003, Science Asia
29:95-98).
In bone, regions of dense “cortical’ bone abut on regions of
low-density “trabecular bone. With pore sizes decreasing
from the core to the exterior, bone is able to maintain a highly
permeable core and yet provide outer wall structural integrity.
In the avian eggshell, a GCS achieves desired mechanical
performance and a necessary permeability. From inside to
outside, the pore size varies from several 100 nm to a couple
of microns (Zhanget al., 2005; Kitimasak et al., 2003), allow
ing for exchange of matter between the outside and inside of
the eggshell while ensuring enough strength to prevent the
shell from cracking caused by collision or impact. In Sum
mary, GCSs have the ability to integrate different, often con
tradictory, functions and achieve an optimized design.
The biomimetic devices of the invention present high struc
tural integrity, with regulated variation of permeability
throughout the device. Furthermore, variation of mechanical
properties of the structure of the device of the invention may
be controlled to match other materials at the interface of the

device and the body.
Composite Surgical Fixation Devices
Surgical fixation devices have to be biocompatible, i.e.,
they may not cause an inflammatory or immune response in
the body. However the current devices lack bioactive features.
Specifically, these devices do not actively promote bone heal
ing and regrowth, Subsequently leaving Voids in the tissue
once the implanted Surgical fixation device is removed (metal
device) or fully degraded (biopolymer device).
The composite bioactive fixation device of the invention
promotes bone healing and regrowth, based on the following
engineering design criteria. The device of the invention is
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strong enough to withstand the mechanical stress during
insertion and post-operative activity. Its degradation may be
controllable to coincide with the rate of tissue growth. The
fixation device of the invention may avoid the need for future
implant removal operation due to adverse reactions or
implant loosening.
The Surgical fixation devices of the invention, Such as, but
not limited to, Surgical screws, have two unique and critical
components: (1) inclusion of nanodiamonds, which dramati
cally improve the mechanical properties of the biomaterials
and serve as a biocompatible non-toxic scaffold to Support
growing cells; (2) porous shell structures for gradual release
of hydrogels containing bone healing drugs (such as bispho
sphonates, alendronate, ibandronate, risedronate, Zoledronic
acid, estrogen, raloxifene, calcitonin, or teriparatide), growth
factors (such as bone morphogenetic protein 2 (BMP2), lacto
ferrin, OxiplexTM (FzioMed, San Luis Obispo, Calif.) or bone
growth factor rhGDF-5), antibiotics (such as Vancomycin,
clindamycin, tobramycin gentamycin, teicoplanin or syner
cid, or combinations thereof), anti-inflammatory drugs, bone
cells, and bone stem cells, from a center core. The composite
bioactive Surgical devices of the invention also serve as scaf
folds for osteoblasts to migrate into the screw, where they can
proliferate/differentiate and finally form new bone tissue as
the device degrades.
In one embodiment, the orthopedic Surgical device is a
sterile, single-use biodegradable and bioactive fixation sys
tem comprising a composite comprising NDS and poly-Llactic-co-glycolic acid (PLGA) or PLLA.
In another embodiment, the device has embedded bioac

tive reagents such as bone healing drugs, growth factors, bone
cells, bone stem cells, antibiotics, and/or anti-inflammatory
drugs, to accelerate bone?tissue healing and recovery. Until
now there has been no reported work on bioactive Surgical
fixation devices with gradient cellular wall/shell structure and
nanodiamond reinforced polymers for bone tissue engineer
ing. The device of the present invention is entirely composed
of materials with a proven safety record and sufficient
mechanical strength, and promotes faster bone growth than
existing passive/inactive devices.
To fulfill the above design criteria, the surgical fixation
device of the invention has two unique and critical compo
nents: (1) a core that is first used as the device driver interface
and then, after the device insertion, is used as a reservoir to
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store Syringe-injected hydrogel containing bioactive materi
als, and (2) an interconnective porous wall/shell, which
allows local, controlled delivery of the biomaterials in ques
tion. The porous device also serves as a scaffold for osteo
blasts to migrate into it, where they can proliferate/differen
tiate and finally form new bone tissue as the device degrades.
In one embodiment of the invention, the Surgical fixation
device is a screw, pin, rod, anchor or staple.
In another embodiment of the invention, the Surgical fixa
tion device is a screw.
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In yet another embodiment of the invention, a design for a
bioactive interference screw is represented in FIG. 5. This
screw may be used for ACL fixations, in a non-limiting
example.
The screw possesses a rounded blunt posterior portion to
prevent graft damage. The screw is tapered and without head
so that it will not protrude out of the drilled hole. The tapered
feature is specifically designed to provide maximum pull-out
strength in ACL reconstruction. The Screw is slightly more
tapered at the tip to facilitate insertion taking into account the
tight fit at this locale. In addition, these screws include full
length tapers so that the highest insertion torque is only real
ized once the screw is fully inserted, as to increase fixation
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and pullout strengths (Agrawal & Athanasiou. “A New Tech
nique to Control the pH in the Vicinity of Biodegradable
Implants.” in Fifth World Biomaterials Congress, 1996, Tor
onto, Canada; De Groot, “Degradable ceramics, in “Bio
compatibility of Clinical Implant Materials. D. F. Williams,
Ed., CRC Press: Boca Raton, Fla., 1981, pages 199-222). A
reduced thread pitch (the axial distance per screw turn) eases
insertion by effectively reducing the screw “lead’, which the
screw uses to travel into the bone tunnel. This difference in

“lead’ reduces the stress within the screw as it is turned,

10

ensuring that the screw is not subjected to forces beyond the
material limits.

The design incorporates a tapered screw and a tapered
driver, thus decreasing the insertion stress while maintaining
fixation strength. This design minimizes driver stripping and
screw breaking by optimizing stress distribution and force
transfer. As a result, the tapered design reduces insertion
torque, making insertion easier (Albee, Ann. Surg. 1920,
71 (1):32-39; LeGeros et al., “Significance of the porosity and
physical properties of calcium phosphate ceramics—Biodeg
radation bioresorption. A Task Group Report').

15

18
ture, Particularly, it results in a coarser structure near the core
and a finer one at the surface. A dwell time of a couple of
minutes at an elevated temperature may result in a significant
amount of structural coarsening. The desired structure may be
approached through adjustment of the two temperatures, i.e.,
core and base temperatures.
Established rapid mold heating techniques (Yao & Kim,
2002, Pol. Eng. & Sci. 42(12):2471-2481;Yao & Kim, 2002,
Pol-Plast. Eng. Technol. 41(5):819-832;Yao et al., 2006, Pol.
Eng. Sci. 46(7):938-945) may be used to rapidly heat the core
and the mold, thus facilitating in situ control to yield the
desired thermal history. In one embodiment, a normal filling
process with a filling time on the order of 1 second is used,
followed by a prolonged holding stage of several minutes, to
thermally condition the phase structure. The actual mold and
core temperatures and the hold time depend on the desired
phase structure that needs to be grown. An inverse design
(Kang et al., 1998, J. Therm. Stresses 21(2):141-155)
approach may be employed for optimizing the thermal his
tory and achieving the desired phase structure.
During selective dissolution, water and biocompatible sol

After the screws are inserted in the bone or tissue, the

vents are used as a first choice. If other solvents are needed,

hollow core of the screws may additionally be filled with
bioactive materials like growth factors, drugs and/or cells at
the time of Surgery in the operating room setting to stimulate
bone growth. For maximum effectiveness, the bone adjacent
to the screw and the bio-reagents in the core are connected
with gradient cellular pores, creating a continuous system that
accelerates bone regrowth upon insertion and filling the Void
upon degradation of the screw (FIG. 5).
Injection Molding of Controllable Porous Structures
Functional porous materials with controllable porous
structures, to be used within the invention, may be prepared
by injection molding an immiscible polymer blend, with spa
tially controlled thermal conditioning to adjust the phase size
and its distribution. Controllable pore sizes and gradient
porous structures may be obtained through control of the
thermo-mechanical history of the blend during processing.
This approach may be further developed for the production of
a gradient porous biomaterial reinforced by nanodiamond
and suitable for applications in implanted devices.
In one embodiment of the invention, polymers such as, but

the extraction is followed by careful flushing in water to
remove all solvent residues. Particularly, a PLA/PCL system
may be tested for its suitability. PCL is another biocompatible
and biodegradable polymer, and it may be extracted with
acetic acid. However, the two polymers have very different
melting temperature, thus increasing the processing diffi
culty.
Other more polar polymers such as polystyrene (PS) may
also be tested. In the case of PS, extraction starts with cyclo
hexanone, followed by an alcohol based solvent, and finally
water. Alternatively, PLA (or PLGA) and PGA may be used to
form a co-continuous phase morphology and Subsequently
the PGA phase may be degraded to form a porous PLA
structure. This approach is based on the fact that PGA has a
much higher degradation rate than PLA. Such a system is
fully biocompatible since no solvent is involved. Another
advantage of this method is that degradation of the PGA
phase can be induced in vivo, allowing the use of a fully dense
screw during insertion.
Mechanical and Biological Testing
The most frequent complication associated with biode
gradable screws is screw breakage during insertion (Evans et
al., 2002, J. Mat. Sci.-Mat. Med. 13(12): 1143-1145; Barberet
al., 2000, Biomaterials 21(24):2623-2629; Lee et al., 2005,
Biomaterials 26(16):3249-3257). Material studies on the
polymer-ND composite of the invention, including compres
sion strength, tensile strength, Young's modulus, and pull-out
strength, may shed light on the breakage problem. Compres
sive and tensile tests may be performed using a Tenius Olsen
H25KT single column materials testing machine (Tenius
Olsen, Horsham, Pa., USA). The maximum torque that may
be applied to the screw may be determined with a torque
meter. Pullout/pushout experiments may be performed using
wood, and model bone, such as polyurethane foams and Saw
bones, both of which are established tests that approximate
the mechanical properties of real bone.
The resorption of the device of the invention in the body
depends on the shape, size and site of implantation. The
polymer resorbable composite should degrade in vivo in a
manner consistent with healthy bone regeneration in bone
augmentation and repair procedures. Without wishing to be
bound by any theory, the fine particles of NDs are actively
released together with fine particles of reduced-molecular
weight PLGA, causing the structure to gradually degrade and
shrink. This system leads to total repair of the bone once the
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not limited to, PLA, PGA, or PLGA, are first melt-blended

with a sacrificial, immiscible polymer (e.g., polystyrene) in a
batch mixer to ensure the development of a fine blend struc
ture with phase size of micrometers. The blend is then injec
tion molded into the mold cavity for the bioactive device
(which may be a screw, in a non-limiting example). While
inside the mold, the blend is thermally conditioned with
higher temperature at the core and lower temperature at the
Surface, resulting in the development of coarse phases at the
core but fine phases at the surface. The interfacial surface
tension between the two polymers causes coarsening of the
phase structure at high-temperature regions. The gradient in
phase size may be regulated by adjusting the thermal history.
When the desired growth is reached, the mold is cooled and
the screw is ejected. Finally, the sacrificial polymer in the
screw is selectively dissolved to obtain desired porous struc
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tures.

To make a porous screw with a gradient, special handling is
needed to create a suitable thermal boundary condition (FIG.
6). For this purpose, a thin cartridgeheater is embedded in the
hexagonal core to control the core temperature. A separate
heating/cooling unit is employed in the mold base. This setup
allows differential control of temperature from the surface to
the core of the molding polymer. The different thermal history
results in different degrees of coarsening in the phase struc
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device is completely disintegrated. This in vivo situation may
be simulated in vitro by incubating and maintaining the bio
active screws under aseptic conditions in complete cell cul
ture medium supplemented with 20% bovine serum. The
decrease in molecular weight of the PLGA over time indi
cates the progression of degradation. The weight loss is mea
Sured over time and a comparison of cross-sectional images
of the degrading bioactive device is made to determine the
degradation rate of the device in vitro testing.
ND Composite Material Biotesting on Toxicity and Biocom
patibility
Toxicity Screening
Toxicity of the materials included in the invention may be
tested using extraction assays. Extracts are prepared by incu
bating Surgical device material for up to 30 days in protein
containing culture medium. Human osteoblasts (ATCC,
CRL-1 1372) are cultured in MEM culture medium supple

20
6 should be considered to have specifically disclosed sub
ranges such as from 1 to 3, from 1 to 4, from 1 to 5, from 2 to
4, from 2 to 6, from 3 to 6 etc., as well as individual numbers

within that range, for example, 1, 2, 2.7, 3, 4, 5, 5.3, and 6.
This applies regardless of the breadth of the range.
The following examples further illustrate aspects of the
present invention. However, they are in no way a limitation of
the teachings or disclosure of the present invention as set forth
herein.
10

EXAMPLES

The invention is now described with reference to the fol
15

Materials:

mented with 10% fetal calf serum and antibiotics, with cell

free medium as negative controls. Potential toxicity-induced
changes in cell morphology and detachment are monitored by
fluorescent and Scanning electron microscopy. Cell viability
and proliferation are quantified over a 30-day period by using
the Alamar blue assay (Mondrinos et al., 2006, Biomaterials
27(25):4399-4408; Nikolaychiket al., 1996, J. Biomater. Sci.
Polym. Ed. 7:881-891).
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Cell Attachment and Proliferation

Cell attachment and proliferation may be assessed by seed
ing composite disks with human osteoblasts. Composite
materials are cast under aseptic conditions into 10-mm diam
eter 1.5-mm thick disks, to fit in 24-well plates. Following
seeding, cell viability is assayed for up to 30 days using the
Alamar Blue assay (Nikolaychik et al., 1996), Cell distribu
tion in the disks is quantified after fixation and sectioning (10
um) by light microscopy, following staining with hematoxy
lin and eosin, as well as by fluorescence microscopy of thicker
sections (60 um) after staining the nuclei and microfilaments
with, respectively, Hoechst 33258 and rhodamine phalloidin
(Li et al., 2006, Biomaterials 27(13):2705-2715; Li et al.,
2005, Biomaterials 26(30):5999-6008).
Those skilled in the art will recognize, or be able to ascer
tain using no more than routine experimentation, numerous
equivalents to the specific procedures, embodiments, claims,
and examples described herein. Such equivalents were con
sidered to be within the scope of this invention and covered by
the claims appended hereto. For example, it should be under
stood, that modifications in reaction conditions, including but
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Unless otherwise noted, all starting materials and resins
were obtained from commercial Suppliers and used without
purification.
Nanodiamonds (NDs) of UD50, UD90 and UD98 grades
were obtained from NanoBlox, Inc. (Boca Raton, Fla., USA).
The number in the grade roughly corresponds to the diamond
to-graphite ratio in the material, as shown in FIG. 4.
Commercial and gas treated samples of NDs were charac
terized by Raman spectroscopy, using a Renishaw RM2000
UV Raman microspectrometer (0.325 nm) (Renishaw,
Gloucestershire, UK); FTIR spectroscopy, using a Digilab
Excalibur spectrometer (Digilab, Holliston, Mass.) with
UMA 600 microscope; and High Resolution Transmission
Electron Microscopy (HR-TEM) using a JEOL 2010F micro
scope (JEOL, Tokyo, JP).
Octadecylamine functionalized nanodiamond (ODA)
powders were obtained from NanoBlox, Inc. (Boca Raton,
Fla., USA).
PLLA was purchased from PURAC (Gorinchem, Nether
lands).
All cell culture media and supplements were from Hyclone
(Waltham, Mass.). Disposable tissue culture supplies were
from Fisher Scientific (Pittsburgh, Pa.).
Gas Treatment:

45

not limited to reaction times, reaction size/volume, and

experimental reagents, such as solvents, catalysts, pressures,
atmospheric conditions, e.g., nitrogen atmosphere, and
reducing/oxidizing agents, with art-recognized alternatives
and using no more than routine experimentation, are within
the scope of the present application.
It is to be understood that wherever values and ranges are
provided herein, all values and ranges encompassed by these
values and ranges, are meant to be encompassed within the
Scope of the present invention and should not be construed as
an inflexible limitation on the scope of the invention. More
over, all values that fall within these ranges, as well as the
upper or lower limits of a range of values, are also contem
plated by the present application. Moreover, all values that
fall within these ranges, as well as the upper or lower limits of
a range of values, are also contemplated by the present appli
cation. The description of a range should be considered to
have specifically disclosed all the possible Sub-ranges as well
as individual numerical values within that range and, when
appropriate, partial integers of the numerical values within
ranges. For example, description of a range such as from 1 to

lowing Examples. These Examples are provided for the pur
pose of illustration only, and the invention is not limited to
these Examples, but rather encompasses all variations that are
evident as a result of the teachings provided herein.
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Gas treatment has been performed in the apparatus
described in the literature (Dash et al., 2004, Micropor. Meso
por. Mat. 72C1-3):203-208) using air, argon, H., Cl, and
NH. Air was of “breathing quality” and other gases were of
“high purity” or “ultra high purity' grades as supplied by Air
Gas (USA).
The samples were treated according to the following pro
tocol. ND powder (0.3-0.5 g) was placed into a quartz, boat,
weighed and inserted into a quartz tube positioned inside a
tube furnace. The furnace tube was isolated from the atmo
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sphere and purged with argon (30 ml/min) at room tempera
ture for 1 hour to remove the ambient atmosphere. After
purging, the flow of a reagent gas was started (30 ml/min), and
heating was turned on. Upon achieving the desired tempera
ture, the sample was held at this temperature under the
reagent flow for a specified time. The furnace was switched
off and the sample was allowed to cool to room temperature
under the reagent gas flow. At the end of the experiment, the
tube was purged with the inert gas for several hours to remove
any traces of the reagent. Upon completion of the treatment,
the quartz boat with the sample was removed from the tube
and weighed again to determine weight change.
Nanocomposites Preparation:
PLLA (1 g) was dissolved in 10 ml of chloroform. A
moderate amount of ND or ND-ODA calculated by weight
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percentage was weighed and put into 20-ml vial. After addi
tion of 10 ml of chloroform, the mixture was placed under
high power sonic for 30 min, then mixed with PLLA/chloro
form solution immediately. The solvent in mixture was
evaporated under stirring. The resulting thick film was used
directly for further measurement.
Mechanical Tests:

Two kinds of ND powders were used: air-oxidized HC1
purified ND, and hydrophobic ND terminated with long ali
phatic chains of octadecylamine (ND-ODA). Both powders
were supplied by NanoBlox, Inc. The hardness tests were
performed on Wilson Rockwell Hardness Tester (Instron
Worldwide Headquarters, Norwood, Mass., USA). Six-ten
point for each samples were measured.
In Vitro Biocompatibility:
In view of the long-term goal of generating scaffolds for
bone tissue engineering, the U2OS osteosarcoma cell line
was used for the study of cell attachment and proliferation on
PLLA/ODA scaffolds. 7F2 cells were routinely maintained in
alpha minimum essential medium (CMEM) with 10% FBS,
2.0 mM L-glutamine, 1.0 mM sodium pyruvate (VWR) in a
5% CO, incubator at 37° C. The scaffolds were incubated
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transferred from water to 200-mesh CuTEMgrid. Samples of
ND-ODA suspension in chloroform were dropped on the Cu
TEMgrid with lacey carbon film and left to dry. TEM images
were obtained with a JEOL, JEM 2100 microscope at 200 kV.
Photographs at different magnification were taken from sev
eral randomly selected spots on the grid to ensure that the
results are representative.
Scanning Electron Microscopy (SEM):
To assess the morphology of 7F2 cells cultured on various
ND-ODA/PLLA scaffolds by scanning electron microscopy
(SEM), samples were dried with a critical point dryer (CPD,
SPICPD 7501, West Chester, Pa.) and characterized with an
XL-30 Environmental SEM-FEG (Philips) using an accelera
tion Voltage of 10kV according to standard protocol (Lietal.
2005, Biomat. 26:5999-6008). A total of 3-4 images from
independent preparations were evaluated.
Depth Sensing Indentation and Vickers Indentation:
Depth sensing indentation was performed using an MTS
NanoIndenter XP (MTS, Eden Prairie, Minn.) with a 17 um
radius spherical tip. Indentation experiments were performed
using continuous stiffness mode, according to the manufac
turers instructions. All tests were recorded at a constant

with 5% fibrin for 30 minutes to enhance cellular attachment.

strain rate of 0.05s' up to an indentation depth of 1,500 nm

Then, the scaffolds were transferred to 24-well plates and
seeded with a density of 50,000 cells/well. After 3 days, the
samples were fixed in 10% neutral buffered formalin for 1
hour at room temperature and then left overnight in 1xpBS at
4°C. The samples were washed once with 1xPBS, and the
cells were permeabilized for 15 minutes in 0.2% Triton-X 100
(Sigma-Aldrich, St. Louis, Mo.) in PBS (Cellgro, Manassas,
Va.). Following a gentle wash in 1xRBS, the samples were
incubated for 15 min in PBS containing 2 g/mL Hoechst
33258 (bis-benzimide, Sigma-Aldrich) and 1 lug/mL
rhodamine phalloidin (Phalloidin, TRITC-labeled, Sigma
Aldrich). Samples were visualized on a Leica DMRX micro
Scope equipped with the appropriate fluorescence filters.
Digital images were acquired using a Leica 300F camera.
Differential Scanning Calorimetry (DSC):
The thermal properties of the pure PLLA, 3 wt % ND
ODA/PLLA and wt % ND-ODA/PLLA composites were
studied by DSC (TA Instruments DSC Q100, TA Instruments,
New Castle, Del.), using 10 mg of various samples. All mea
Surements were performed under nitrogen atmosphere at a
heating rate of 10°C/min. All experiments were performed
twice, yielding similar results.
Nuclear Magnetic Resonance (NMR):
The solid-state NMR experiments were carried out using a
Bruker DMX500 (11.7T) spectrometeroperatingata Larmor

and the maximum load was held for 10 s to record creep.
Unloading was performed to 10% of the maximum peak load
followed by an additional 30s hold segment for thermal drift
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correction. The modulus and hardness values were calculated
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frequency of 125.8 MHz for C. A tripletuned magic-angle

spinning (MAS) probe was used. The 4 mm Zirconia rotor
containing roughly 70 mg of sample was spun at 12.5 kHz
with automatic spinning control. Recycle delays of up to 64s
were used in direct polarization experiments while a recycle

delay of 2 s was used in "H-C cross polarization experi
ments. The 'Cand HTL/2 pulse lengths were 5 usandTPPM
decoupling of H was used during detection. Tetramethylsi
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lane was used as an external chemical shift reference for C.

Dynamic Light Scattering (DLS):
ND-ODA particle size in PLLA/chloroform solution was
measured at 20°C. in back scatter geometry using a Malvern
Zetasizer Nano ZS (Malvern Instruments Ltd, UK) equipped
with a 10 mW He Ne laser (633 nm).
Transmission Electron Microscopy (TEM):
For Transmission Electron Microscopy (TEM) of the ND
ODA/PLLA films, the samples were sectioned at about 100
nm with a diamond knife using an Ultramicrotome Leica
Ultracut EMUC6 at room temperature, and the sections were

60

65

after effective Zero point correction as recommended by
Kalidindi et al. (Acta Mater 2008, 56:3523-32) from the
initial 50 nm elastic indentation segment. Stress-strain data
were derived using the nanoindenter stiffness signal which
was analyzed as described in literature (Kalidindiet al., 2008,
Acta Mater 56:3523-32). Each sample was tested 10 times
and one representative (near the middle of the set) curve of 10
was used for load-displacement and stress-strain analysis.
Vickers indentation tests were performed with a LECO
M-400 Vickers hardness testing machine using a testing force
of 2.94 N. The indents were photographed with an Olympus
PMG3 light microscope.
X-Ray Diffraction (XRD):
XRD patterns were recorded using a Rigaku SmartLab
X-ray diffractometer (Rigaku Corporation, Japan) with Cu
KC. Source. Samples were prepared by Solvent casting on
silicon wafer. The data were collected with a step size of 0.01°
(20) and count time 2s per step between 10 and 30° (Kruger
et al., 2005, Carbon 43:1722-30).
Real-Time Quantitative Polymerase Chain Reaction (RT
qPCR):
Total RNA was isolated with RNeasy Mini Kit (Qiagen,
Valencia, Calif., USA). Genomic DNA was digested with
RNase-free DNase set (Qiagen) according to the manufactur
er's protocol. Following RNA isolation, the quality and quan
tity of the extracted RNA were analyzed with a Nanodrop
1000 (Thermo Fisher Scientific, Inc.). 0.6 g of RNA was
reverse transcribed with high capacity cDNA reverse tran
scription kit (Applied Biosystems, Foster City, Calif., USA).
RT-qPCR was carried out using Taq-Man Universal PCR
master mix (Applied Biosystems) and specific primers for
osteocalcin (OCN, assay ID: Mm 03413826 mH) and alka
line phosphatase (ALP assay ID: Mm 1187113 g1) on a
Stratagene MX3000P QPCR system (Agilent Technologies,
Inc., USA). A comparative Ct method was used for analyzing
the targeted gene expression levels, which were normalized to
the Ct value of Taqman R) murine housekeeping gene pepti
dylprolyl isomerase A (cyclophilin A, PPIA, assay ID: Mm
02342430 g1*). Relative fold of change was then calculated

as 2^^. Each experiment was carried out independently
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A UV Raman spectrum of ND-ODA 3 (FIG. 8) revealed
typical features of nanodiamond: a broad and downshifted

23
three times and each sample was analyzed in duplicate. Sta
tistical significance of the data was evaluated as described
below.
Statistical Analysis:
All biological experiments were performed at least three
times. Wherever possible data are expressed as mean fstan
dard deviation (SD). Statistical analyses were performed
using either ANOVA one-way analysis or ANOVA two-way
analysis when applicable and significance was considered at
p<0.05.

peak of diamond at 1327 cm and a broad intense peak at
1630 cm. The unresolved peaks of C H (at -2980 cm)
and N—H (at ~3200 cm) were also present in agreement
with the structure 3. These latter Raman peaks overlapped
with the second-order spectrum of sp carbon in ND.
A model of a single ND-ODA particle is shown in FIG.
18b. Analysis of ND-ODA by C NMR provided evidence
10

Example 1

perhaps additional carbon atoms of ODA in H to C cross

Preparation and Characterization of Derivatized ND
Particles

15

30 mg of ND, corresponding to compound 1 in reaction
(IV) (UD90 grade, NanoBlox, Inc., USA), was purified by air
oxidation and cleansed of metal impurities by boiling in 35%
witHCl for 24 hours, and then refluxed with 50 mL of SOCl,
(Sigma Aldrich) and 1 mL of anhydrous N,N-dimethylforma
mide (DMF) (Sigma Aldrich), a well known catalyst for this
reaction, at 70° C. for 24 h.
25

(IV)
O

ND-(

O

SOCl.

ND

CH3(CH2)3NH2.

OH
1

for the covalent linking of the ODA chains to the surface of
ND (FIG. 18c). In particular, signals of first, second, and

C

30

polarization spectra of ND-ODA were missing due to inter
actions of the atoms near the amine end of ODA with the large
ND particle. Similarly, the missing signals of carbon atoms
nearest to the amide bond have been reported before for ODA
covalently linked to carbon nano-onions (Rettenbacher et al.,
2006, Chem, Eur. J. 12:376-87) and multi-walled carbon
nanotubes (Xu et al., 2003, Chem. Phys. Lett. 375:598-604).
The disappearance was due to a combination of broadening
effects including the increased steric hindrance, variations in
local structure, and the presence of paramagnetic species.
These effects suggested a covalent linkage between the ND
and ODA. As a result of this covalent linkage, ND-ODA is
hydrophobic and strongly fluorescent in contrast to as-re
ceived non-modified ND. FIG. 18d shows High Resolution
Transmission Electron Microscopy (TEM) image of ND
ODA particles with lattice fringes at 0.206 nm (111 planes
of diamond) surrounded by, presumably, the ODA chains.
Purified ND-ODA powder 3 was used in subsequent stud
1CS

2
O

Example 2

ND-(
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Surface-Functionalized NDs in PLLA

3

After removing the brown-colored liquid, compound 2 in
reaction (IV) was washed with anhydrous tetrahydrofuran
twice, and then dried at ambient temperature in a desiccator
under vacuum. About 30 mg of the acyl chloride derivative 2
was stirred in a sealed flask with 1 g of octadecylamine, also
known as ODA (Sigma Aldrich), at 90-100° C. for 96 hours.
After cooling, excess ODA was removed by sonication with
anhydrous methanol (Sigma Aldrich) 4-5 times. To remove
adsorbed ODA, the material 3 in reaction (IV) was further
purified by extraction with hot methanol in a Soxhlet appa
ratus. To ensure complete extraction, it was repeated 10 times
with fresh methanol.

The sequence of reactions was monitored by FT-IR analy
sis of the products 1-3 (FIG. 7). C=O stretch vibrations in an
acyl chloride derivative of ND were shifted to a higher fre
quency compared to the C=O band in ND, thus indicating
the conversion of COOH into —COCl (spectrumb in FIG.
7). Treatment of acyl chloride derivative with ODA resulted
information of the amide III (spectrum din FIG. 7). IRAmide

Due to the long hydrocarbon chains linked to its surface,
the ND-ODA could be easily dispersed in hydrophobic sol
40

DMF, ethanol, methanol, and acetone.
45
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3000 cm characteristic of long hydrocarbon chains, and the
N-H stretch of the amino group at 3300 cm', could not be

considered alone as proof of the amide 3 formation, because
they might appear in the spectrum simply as a result of ODA
physisorption.

vents such as benzene, toluene, chloroform, and dichlo
romethane. At the same time, it was immiscible with water

and poorly miscible with hydrophilic organic solvents such as

I and Amide II bands at 1650 and 1550 cm, respectively, in

the spectrum of 3 (spectrum d in FIG. 7) provided a proof of
covalent attachment of ODA through the amide bond forma
tion, as opposed to physisorption of ODA. Other IR features
of ND-ODA, such as strong C–H stretch vibrations at 2800

Dispersion of Non-Functionalized and

65

After being dispersed in toluene with ultrasonication, NDs
completely precipitated within 1 hour (FIG. 9). On the other
hand, ND-ODA without any sonication or other means
formed a clear, stable pale yellowish (or brown at high con
centrations) colloidal solution, which showed no visible pre
cipitation over a week. Particle size measurements revealed
100-300 nm ND-ODA agglomerates in toluene and chloro
form (FIG. 9) in contrast to 5,000-9,000 nm agglomerates
formed in DMF. No sonication, surfactants, or other special
means of dispersing were necessary for ND-ODA. The solu
bility of ND-ODA, based on gravimetric estimations, was ~4
g/L in dichloromethane and ~3 g/L in toluene.
To test the dispersion of ND in PLLA, mixtures of 6% wt
ND and 6% wt ND-ODA in PLLA/chloroform were pre
pared. The ODA/PLLA mixture was centrifuged at 500 rmp
for 30 min and then kept still for 1 week without any stirring.
During this time, there was no phase separation observed in
the mixture (FIG. 10b).
However, the suspension of ND/PLLA prepared in the
same way in chloroform precipitated within 1 day of standing
without any centrifugation (FIG. 10d). This result suggested
that ND-ODA has better dispersion in chloroform/PLLA sys
tem than ND. This result also suggests an interaction between
ODA and PLLA.

US 9, 186,190 B2
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The hydrodynamic diameter of ND-ODA in PLLA-chlo
roform Solutions determined by Dynamic Light Scattering
(DLS) was narrowly distributed around maxima at 33+3 nm

26
Example 5
Epoxy-ND Composites

for 1% wt NDODA/PLLA and 28-2 inn for 10% wt ND

ODA/PLLA, respectively (FIG. 19a). Given the 5 nm diam
eter of primary ND particles, one could conclude that the
sizes measured by DLS correspond to aggregates of >5 par
ticles. However, the length of an ODA chain linked to ND
appears to be about a half of the diameter of an ND (2.5 nm,
FIG. 18b), i.e. the diameter of ND-ODA primary particles
could be as much as twice larger than 5 nm. Thus the hydro
dynamic diameters measured by DLS are likely those of small
ND-ODA aggregates composed of just a few particles.
The dispersion of ND-ODA in a solid PLLA matrix was
observed by TEM of ultrathin sectioned samples (100 nm
thick) containing 1, 3, and 10% wt of ND-ODA. At 1% wt
concentration, low resolution TEM images (FIG. 19b) sug
gested Small ND-ODA agglomerates, tens of nanometers in
size. No further increase in the agglomerates size or density
was observed at higher concentrations (FIGS. 19.c and 19d),

5

10

15

Two kinds of ND powders were used: air oxidized HCl
purified ND, and a special NH2-terminated nanodiamond,
produced by selective conversion of the ND surface COOH
groups into amino groups. NH2-terminated ND was expected
to react with epoxy resin and form strong covalent ND/poly
merinterface, resulting infurther improvement in mechanical
properties of the composites.
Compared to the neat epoxy samples (0% wt of ND), the
samples with 5% wt of ND demonstrate higher Young's
modulus and hardness (Table 1). Especially notable is the
about two-fold decrease in creep rate (FIG. 12b) and the
significant increase in hardness that were only observed for
composites with aminated ND. These preliminary results pro
vided an indication of improvement in mechanical properties
of the composites with ND covalently bonded to the polymer
chains.

Instead, when the concentration was increased, intercon

nected particle chains were formed (FIG. 19d). Thus, DLS
measurements and TEM micrographs converge to a conclu
sion that there is no strong agglomeration orphase separation
of ND-ODA and PLLA in the composites up to, at least, 10%

TABLE 1

Young's modulus and hardness of epoxy with and without ND
Sample

wt of ND-ODA.

Example 3
30

Mechanical Tests in PLLA

Results were produced on PLLA with two kinds of ND
powders: air-oxidized HCl-purified ND, and hydrophobic
ND terminated with long aliphatic chains of octadecylamine
(ODA) (Mochalin et al., “High temperature functionalization
and Surface modification of nanodiamond powders. In
“Materials Research Society Symposium Proceedings Bos
ton, MA, USA, 2007, Vol. 1039, 1039-P11-03). The hard
ness tests were performed on a Wilson Rockwell Hardness
Tester (Instron Worldwide Headquarters, Norwood, Mass.).
FIG. 11 depicts the hardness of the composites produced

Compositions of PA-1 1/ND with up to 20% wt of ND were
produced in the form of nanofibers and thin films from oxi
dized and HCl purified ND (UD90-grade) supplied by Nano
Blox. Addition of ND significantly improved mechanical
properties of PA-11 films, raising their Young's modulus by a
factor of 4 and more than doubling the hardness (FIG. 12a).

Young's Modulus, GPa.

Hardness, GPa.

2.7
5
6.3

O.17
O.18
O.23

curves derived from these data are illustrated in FIG. 20b.
35
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Young's modulus and hardness of the composites, calculated
after effective Zero point correction (Kalidindi et al., 2008,
Acta Mater. 56:3523-32), are presented in FIG. 20f. The
experimental Young's modulus of the PLLA thin film was
2.6+0.1 GPa, which agrees well with the value of 2.05 GPa
reported for the amorphous PLLA film by Martin et al. (Poly
mer 2001, 42:6209-19). The measured hardness of the PLLA

film was 0.05+0.01 GPa. The modulus and hardness of our

45

50

PLLA thin films were lower than those previously reported
for PLLA samples produced by injection molding (Young's
modulus 4.6 GPa and hardness 0.23 GPa.) (Wright-Charles
worth et al., 2005, J. Biomed. Mater. Res A74A:388-96). This
may be explained by different crystallinity of the present
PLLA samples produced by Solution casting (more amor
phous PLLA) and those reported in literature, which were
Subjected to elevated temperature and mechanical drawing
during the injection molding process (more crystalline
PLLA).
Introduction of ND-ODA into the PLLA matrix resulted in

55

Example 4
Mechanical Tests in PA-11 (Polyamide-11)

O% wt. ND
5% wt. non-aminated ND
5% wt. aminated ND

Shown in FIG.20a are load-displacement curves for ND
ODA/PLLA obtained by nanoindentation, Stress-strain

with ND and ND-ODA. The hardness increased about 2 times

when adding 0.5% wt. of air oxidized HCl purified ND into
PLLA. However, it decreased when adding more air oxidized
HCl purified ND (1% wt) into the biopolymer. This behavior
is similar to results of d'Almeida et al. (J. Reinf. Plast. Comp.
2007, 26(3), 321-330) and is due to a poor dispersion of the
purified but non-functionalized ND in the polymer.
In contrast, addition of 1% wt of ND-ODA (functionalized
ND) increased the hardness of the composite dramatically
(>4 times). These results provide strong evidence of improve
ment in mechanical properties produced with the use of func
tionalized ND composites within biocompatible and biode
gradable composites.

reinforcement.

25
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an increase in the mechanical properties at all concentrations
studied (FIG.20?). Supplementation with 1% wt of ND-ODA
yielded a 207% higher Young's modulus and 420% higher
Meyer's hardness. Further increase in ND-ODA content pro
duced a marked reduction of 35% in creep (FIG.20a) and led
to a further, though less pronounced increases inhardness and
modulus with smaller changes at higher ND-ODA loads.
Similar effects were recently reported for ND/poly(vinyl
alcohol) composites (Maitra et al., 2009, Solid State Com
mun. 149:1693-97) where the most dramatic increase in
Young's modulus and hardness occurred at very low concen
trations of ND (0-0.2% wt). Thus the present experimental
results suggest that even at low ND content a significant
improvement in mechanical properties of the polymer matrix
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may be achieved given the ND has good affinity and is uni
formly distributed in the matrix. In the case of PLLA-based
composites strongly hydrophobic filler, such as ND-ODA,
are preferred, since this material has good affinity to PLLA
and may be well dispersed in hydrophobic solvents (such as
chloroform) that are used in solution casting of PLLA. The
crucial role of the hydrophobicity of ND-ODA is emphasized
by a comparison with the results for as-received hydrophilic
ND terminated with oxygen containing functional groups
(Osswald et al. 2006, J. Am. chem. Soc. 11635-42) (FIG.20?.
last two rows). In contrast to ND-ODA, the additions of 1 and
3% wt of the asr-eceived ND (UD90) did not produce any
significant changes in Young's modulus and led to a much
Smaller increase in hardness. Interestingly, when non-modi
fied diamond particles with no affinity to the matrix were
added, sometimes even a concentration-dependent decrease
in mechanical properties of polymer matrix was observed,
which may be due to poor dispersion and poor adhesion
between the diamond particles and the matrix (d. Almeida et
al., 2007, J. Reinforc. Plast. Compos. 26:321-30).
Vickers indentation provided further evidence for a dra
matic improvement in the elastic recovery of the ND-ODA/
PLLA samples. In contrast to a clear Vickers imprint in pure
PLLA (FIG. 20c), an imprint left in a 10% wt ND-ODA/
PLLA was hardly visible (FIG. 20d), suggesting almost com
plete elastic recovery in the latter case. To explain the
observed improvement in mechanical properties of PLLA
upon addition of ND-ODA, two possible mechanisms could
be considered. First, the improvement could be due to intrin
sic high hardness and Young's modulus of the nanodiamond.
Second, the nanofiller could increase the crystallinity of the
polymer matrix which also translates into higher hardness
and Young’s modulus of the composite. To understand how
ND-ODA influences the crystallinity of PLLA, X-Ray Dif
fraction (XRD) patterns of pure PLLA and 10% witND-ODA/
PLLA thin films were recorded, both produced by solution
casting. In order to compare the crystallinity, the XRD pat
terns of the films were normalized to the maximum intensity
without background correction (FIG. 20e). The diffraction
from the crystalline regions that were present even in amor
phous PLLA had several characteristic maxima, the two
strongest are at 20 of ~17° and ~19 corresponding to a
typical PLLA pseudoorthorhombic C. structure (Hoogsteen et
al., 1990, Macromol. 23:634–42). These peaks were present
in XRD pattern of the neat PLLA film (FIG.20e) on top of a
well-pronounced amorphous halo from 100 to 200. The XRD
pattern of 10% wt ND-ODA/PLLA film also showed clear
Bragg peaks of PLLA crystalline phase at 20 of ~17° and
~19 (corresponding to (110) crystal reflection; Wang et al.,
2001, Polymer 42:8965-73), with a significantly suppressed
amorphous halo, which was indicative of increased crystal
linity of the composite compared to the neat PLLA film. The
peaks at ~17° were fit with Lorentz functions. FWHM (Full
Width at Half Maximum) values obtained from the peak
fitting are 0.563+0.007 for neat PLLA and 0.474+0.0070 for
10% wt ND-ODA/PLLA. The narrower peak of 10% wt
ND-ODA/PLLA provided further evidence of the higher
crystallinity of ND-ODA/PLLA. Thus, well-dispersed ND
ODA particles increased crystallinity of the PLLA matrix,
which in turn led to the enhanced hardness and Young's
modulus of the composite.
Example 6
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history. When PLLA is combined with nanodiamonds togen
erate composites, the properties of the resulting material may
differ from the original properties of PLLA.
In order to assess the biocompatibility of ND-ODA/PLLA
composites, osteosarcoma cells (U2OS cells) were seeded on
pure PLLA and ND-ODA/PLLA (0.5% wt of ND-ODA)
scaffolds, FIG. 13 shows the cell morphology after 3 days cell
culture, demonstrating that ND-ODA/PLLA scaffold Sup
ported cell attachment. The cell attachment on ND-ODA/
PLLA scaffold was as good as on pure PLLA scaffold, as
visualized by nuclear staining with bisbenbenzimide (Ho
echst 33258). This result indicated that the ND-ODA/PLLA
composites are biocompatible and may be used for tissue
engineering.
ND is known to be less cytotoxic than carbon black or any
other known carbon nanomaterial (Schrand et al., 2009,
“From manufacturing to medical applications.” New York:
Springer: 2099, p. 159-87). However, cytotoxicity may be
affected by ND functionalization. In order to determine the
toxicity and biocompatibility of ND-ODA, the effects of
native and functionalized ND on murine 7F2 osteoblast cells,
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using the fluorescent alamarBlueTM (AB) assay, were tested.
The exposure of the cells to either ND or ND-ODA in con
centrations up to 100 ug/ml resulted in a slight (though sta
tistically not significant) reduction in cell viability compared
to control, i.e. untreated cells grown on tissue culturetreated
polystyrene, TCP (FIG. 24). This result suggested that, in the
presence of ND or ND-ODA, the cells survived and grew
essentially normally. ND with diameters 2-100 nm at concen
trations up to 1000 ug/ml are nontoxic for different cell types,
Such as neuroblastoma, kidney, and epithelial cells (Schrand
et al., 2007, J. Phys. Chem. B 111:2-7: Chao et al., 2007,
Biophys. J. 93:2199-2208). The present results suggest that
NDs with ODA attached are nontoxic for 7F2 osteoblasts.

35

In addition to ND and ND-ODA powders, biocompatibility
ofND-ODA/PLLA composites was also tested. In these stud
ies, osteoblasts were seeded on scaffolds made of PLLA

40
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containing 0-10% wt of ND-ODA and, on glass and TCP
substrates as controls. The osteoblasts proliferated similarly
on all Substrates during the 6 days of culturing with only
small, statistically insignificant differences (FIG. 25). FIG.
21 illustrates a typical SEM image of the porous structure of
the 10% witND-ODA/PLLA thin film produced through solu
tion casting. Porous structure formed as a result of Solvent
evaporation facilitated cell attachment and growth. Due to the
presence of ND-ODA in the PLLA matrix, the film showed
blue and red fluorescence under excitation at 360 and 555 nm.

(seen as light areas in the figures: FIGS. 21b and 21c), which
coincide with the porous structure observed under SEM. The
50

clear fluorescence of the 10% witND-ODA/PLLA Scaffold in

background of the 7F2 osteoblasts after 3 days post-seeding
(FIG. 21d) indicated the possibility to monitor the composite
degradation in situ.
In order to assess the morphology and cytoskeletal archi
55

60

tecture of 7F2 cells on ND-ODA/PLLA scaffolds, the cells

were fixed after 48 h and 6 days post-seeding. Osteoblasts
attached, spread, migrated, proliferated to confluence within
6 days (FIG. 21d and FIGS. 22a-d) and formed nearly iden
tical monolayers on PLLA and ND-ODA/PLLA, scaffolds.
Scanning Electron Microscopy (SEM) images (FIGS. 22e-f)
confirmed these findings: at day 6 post-seeding 7F2 cells have
become fully confluent on both scaffolds.
The effect of ND on 7 F2 osteoblast differentiation was

Biocompatibility & Cellular Proliferation
65

PLLA is amongst the most commonly used synthetic bio
degradable polymers, with an extensive U.S. FDA approval

quantified by RT-PCR for two osteogenic differentiation
markers, i.e. ALP and OCN. The relative expression levels of
these two genes in 7F2 cells cultured for 48 h and 1 week on
three different scaffolds (PLLA, 10% wt ND-ODA/PLLA,
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and 10% wt UD90/PLLA) were measured and compared to
those in 7F2 cells cultured on TCP for 48 h (FIG. 23). Impor
tantly, there was not any significant difference in the expres
sion of osteogenic marker genes on any of the Substrates at
both 48 and 1 week post-seeding. When comparing the data at
one week to those at 48 h, a significant decrease in ALP gene
expression was observed concomitant with a significant
increase in OCN gene expression (p<0.05 by two-way
ANOVA). In the present system, the results for both ALP and
OCN gene expression levels are in line with the AB assay
data, in that there was no significant difference in any of the
“biomarkers' on any of the substrates. Taken together, the
data from two independent biochemical/molecular assays as
well as from immunocytoechemical staining Suggested that
ND-ODA/PLLA composites with up to 10% witND-ODA are
non-cytotoxic for 7F2 cells; they support 7F2 cell prolifera
tion and osteogenic differentiation to the same extent as con
ventional “gold-standards, such as TCP, and therefore may
be used for tissue engineering and regenerative medicine.
As illustrated above, ND-ODA/PLLA composites with up
to 10% wt ND-ODA showed uniform ND-ODA dispersion
and good affinity between the matrix and the filler. The
mechanical properties of NDODA/PLLA composites were
improved dramatically with the addition of ND-ODA: 1% wt
of ND-ODA increased the hardness of the composites by the

30
PCL after dissolution of the PEO phase (FIG. 15). The blend
was also injection molded into a cold mold. It was found that,
for a 6 mm circular channel, a gradient structure was devel
oped, with finer structure at the Surface and coarser structure
in the center (FIG. 16).
Example 9
Degradation Test
10

15

a refractive index detector. HPLC measurements were carried

25

factor of 4; 10% wt of ND-ODA resulted in almost an order of

magnitude higher hardness, 3 times higherYoung's modulus,
and reduced creep. Cytotoxicity and biocompatibility experi
ments in concert with osteogenic marker gene expression
analysis demonstrated that both ND and ND-ODA are non
toxic to murine osteoblasts, and Support cell proliferation and
differentiation in vitro. The combination of these properties
with intrinsic fluorescence and tunable biodegradability
makes the ND-ODA/PLLA composites promising materials
for bone tissue engineering and regenerative medicine.
Example 7
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INCORPORATION BY REFERENCE
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While the invention has been disclosed with reference to

40

specific embodiments, it is apparent that other embodiments
and variations of this invention may be devised by others
skilled in the art without departing from the true spirit and
Scope of the invention. The appended claims are intended to
be construed to include all such embodiments and equivalent
variations.
What is claimed:

In order to test the influence of ND on thermal behavior of

PLLA, DSC scans were run for pure PLLA, 3% wt ND-ODA/
PLLA, and 5% wt ND-ODA/PLLA composites. The differ
ential heat flow curves of PLLA and ND-ODA/PLLA com
45

1. A nanocomposite material comprising poly-L-lactic
acid (PLLA) and 1-10% by weight of octadecylamine-sur
face-functionalized nanodiamonds (ND-ODA), wherein ND
ODA has the formula of
O

50

ND-(

NH-(CH2)CH,

and wherein the Young's modulus of the nanocomposite
55

material is between 5.1 and 8.0 GPa.

2. The nanocomposite material of claim 1, wherein the
ND-ODA are prepared by peptide bond formation between
octadecylamine and a carboxylate group on the Surface-func

GCS Results

Polycaprolactone (PCL) and polyethylene oxide (PEO)
were used as a model system for the development of continu
ous, gradient porous structures. The blend was first mixed in
a Brabender(R) batch mixer, resulting in a co-continuous struc
ture, with a phase size in the micrometer range. To produce a
structure with continuous pores, the blend was extruded with
different dwell times in the extruder for thermal conditioning,
and finally selectively dissolved in water and dried. It was
found that thermal conditioning can be effectively used to
control the phase structure and thus the porous structure of the

out at 25° C. and at a flow rate of 0.8 ml/min using THF
(tetrahydrofuran) as an HPLC solvent. Polystyrene standards
(Polyscience Co.) were used for calibration.
The results indicated that the molecular weight of PCL
decreased over time and that the effect was more pronounced
in the presence of blood proteins (FIG. 17). During the time
period of 6 weeks, the observed change was small (<1%) but
measurable. The Small change was consistent with the fact
that PCL has a longer ~2 years degradation time.

The disclosures of each and every patent, patent applica
tion, and publication cited herein are hereby incorporated
herein by reference in their entirety.

Thermal Analysis of ND-ODA/PLLA Composites

posites are shown in FIG. 14, indicating no thermal behavior
change of the composites when adding ND-ODA into PLLA.
The addition of ND-ODA resulted in a small shift in T.
which could be considered as a machine error. Importantly,
there was no phase segregation or secondary peaks visible in
ND-ODA/PLLA composites, suggesting that the ND-ODA/
PLLA composites with the concentration of nanodiamond no
more than 5% wt were homogeneous.
Example 8

Degradation experiments were performed by incubating
solid cylinders made of PCL 90/10 and 80/20 PCL-CaP
(calcium phosphate) composites in both a physiological
buffer (DMEM) and upon admixing blood proteins (DMEM
with 10% FBS). The cylinders were harvested at different
times, and the molecular weight distribution of partially
hydrolyzed polymer was analyzed using high performance
liquid chromatography (HPLC, Waters, USA) equipped with

tionalized nanodiamonds.
60
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3. The nanocomposite material of claim 1, further compris
ing a composition comprising at least one bioactive agent
selected from the group consisting of a bone healing drug,
growth factor, bone cell, bone stem cell, antibiotic, and anti
inflammatory drug.
4. The nanocomposite material of claim 1, wherein the
Meyer's hardness of the nanocomposite material is between
0.20 and 0.51 GPa.
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5. The nanocomposite material of claim 1, wherein there is
no phase separation of ND-ODA and PLLA.
6. A Surgical fixation screw, comprising:
an interconnective porous shell, wherein said shell com
prises a nanocomposite material comprising poly-L-lac- 5
tic acid (PLLA) and 1-10% by weight of octadecy
lamine-surface-functionalized nanodiamonds (ND
ODA), wherein ND-ODA has the formula of

32
inserting a Surgical fixation screw in at least one orifice of
a bone or tissue of said patient, wherein said screw
comprises:
an interconnective porous shell, wherein said shell com
prises a nanocomposite material comprising poly-Llactic acid (PLLA) and 1-10% by weight of octade
cylamine-surface-functionalized

nanodiamonds

(ND-ODA), wherein ND-ODA has the formula of

10

O

O

ND-(

ND-(

NH-(CH2)CH,

NH-(CH2)CH,
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and wherein the Young's modulus of the nanocomposite

and wherein the Young's modulus of the nanocomposite

material is between 5.1 and 8.0 GPa, and
a hollow core within said shell, wherein said hollow core is

material is between 5.1 and 8.0 GPa, and
a hollow core within said shell, wherein said hollow core is

closed on the posterior end of said Screw and open on the
anterior end of said screw.

2O

7. The surgical fixation screw of claim 6, wherein said
hollow core is optionally filled with a composition compris
ing at least one bioactive agent selected from the group con
sisting of a bone healing drug, growth factor, bone cell, bone
stem cell, antibiotic, and anti-inflammatory drug.

closed on the posterior end of said screw and open on the
anterior end of said screw, and

filling said hollow core of said screw with a composition
comprising at least one bioactive agent selected from the
group consisting of a bone healing drug, growth factor,
25

bone cell, bone stem cell, antibiotic, and anti-inflamma

tory drug.
8. The surgical fixation screw of claim 6, wherein said
15.
The method of claim 14, wherein said posterior end is
posterior end is tapered with respect to said anterior end.
9. The surgical fixation screw of claim 8, wherein said tapered with respect to said anterior end.
screw has full-length taper.
16. The method of claim 15, wherein said screw has full
10. The surgical fixation screw of claim 6, wherein said 30 length taper.
anterior end is without head.

17. The method of claim 14, wherein said anterior end is

11. The surgical fixation screw of claim 6, wherein said without head.
posterior end is rounded and blunt.
18. The method of claim 14, wherein said posterior end is
12. The surgical fixation screw of claim 6, wherein said rounded and blunt.
shell has controllable varying coarseness, whereby phase of 35 19. The method of claim 14, wherein said shell has con
said nanocomposite material around said hollow core is trollable varying coarseness, whereby phase of said nano
coarser than phase of said nanocomposite material on outside composite material around said hollow core is coarser than
Surface of said screw.
of said nanocomposite material on outside Surface of
13. The surgical fixation screw of claim 12, wherein said phase
said Screw.
controllable varying coarseness is achieved through injection 40 20. The method of claim 19, wherein said controllable
molding.
14. A method of performing an orthopedic Surgery proce varying coarseness is achieved through injection molding.
k
k
k
k
k
dure in a patient, comprising the steps of:

